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A study of the cle2.rance of a tracer 8JTlount of radio-
active vit~~in 312 from SerQ8 was carried out, so that
information on the daily dietary requirement of vit~~in
:812 could oe ootaine,~ by. applying the occupancy principle
to the data, This s tudy was then extended in order to
follow the clearance of vitamin 312 from the individual
oindins- proteins. Information on the whole oody content of
the tracer was used to estimate the total body B12 stores.
In addition to these kinetic studies the distribution
of vita~n 312 added to serlli~ in vitro was also examined.
Tae ratio of added 312 bound to each protein was noted in
different clinical conditions as well as in serum samples
obtained from hospital persoDnel. An investigation was
carried out as to whether the mass of added vitanin 312
affected the percentage bOlli~d by each protein. It was found
that the results were in no way affected. A brief study of
the forms of vitamin B12 carried by each transcobalxuin was
also made but no specificity was observed.
~uring the course of the investigations it was observed
t'clat vit3min 312 was retained on a column of Sephadex G - 200
under condi t Loris whi ch had not oeen previously descri'bed , T'clis
bi.nd.i.ng V;3.S e tud.i ad in detail but was found to be of Lmpoz-tance
q
only in special circillnst~~ces. The work was concluoed with
a comparison of the results obt~ined with jephadex G - 200
and Wit8 other se~~ration materials.
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A B ] R J v I AT! G N
The terms cobals8in and vita~in 312 (312) are used
,fien the native vit23in 312 is being discussed and when
its che8ical form is either not knO\iu or is of no part-
icular relev''m.ce to i~1.e study. B.8.d.io::i.ctive vi t ami.n 1312 is
>::7
This isotope is generally J, CO &~l the labelled vitamin
is
r:.7
referred to ~s ~. 00 cy8llocoba18nin (when the vitamin
is in the cyP.....no-To rra) or alJbrevi2.ted to 57 Co 312.
The abbreviation 'iris' is used for 2 - amino 2
(hydroxymethyl) propane -1, 3 -diol (tris).
In t'2e tables the he.8.ding J312 ng-/l refers to the aerum
vitamin 312 level in n8llograms per litre. ~1.e heading folate
refers for the most part to the serQs folate in nanograms
per litre but on cert:::t.in occae.ions to the whol e blood. folate
or red. cell f'oLabe , T1.1.e unsa.tura'ted serum vat.ami.n B12 bincling
capacity in nanograms per litre is referred to as U3I3C ng/l
and the amou...~t of added radioactive cyanocobalallin bound to
specific carrier proteins is expressed as a pe'rcerrtage bound
on each fraction. The fractions are abbreviated to TCO
(tra.nscooa1amin 0) ,1'01 or a'l tern.'01,tively Tel + III (transcohalamins
I + III) and TCII (tra..'l.scobalamin II). ~']'(lere details of th,~
capaei.ty to absor-b v.i tami,n :B12 are g'iven, the value given under
the coluD!l headed P12 absorption alone refers to the percent~~'e
of a one m.icro2~ram dose of radio'l.ctive cyanocobalamin retained
- 11 -
in the bo dy two weeks after adrninistration, as measur-ed by
Yle value Q~cer the heading B12
h -l- • 1 ~- I. -l-' • ~. t \ - t t'a~sorp0~on :p~us ~J \lnurlnSlC lac or) relers 0 ne
:percent2~e retained in the body using the same tecr~~ique
when the dose of radioactive cy~~ocobal8min is given with
a source of intrinsic factor. On occasions the capacity to
absorb vi t;:'Jnin 312 was measured by the Schilling Test using
a one mi crcgr-am dose of radi02~ctive cyancco ba'lamin and these
values are rnar-kad wi tll an asterisk. The headin~' maz-row refers
to the state of erythropoiesis and normo is an abbreviation
for normoblastic. The abbreviation ~~.';.C refers to t1:1e max.irna'L
acid output usu8.11y in response to pentag8.strin 2nd the values
are given as mi.LlLe qu.Lva.Lenta in the hour after stimulation.
T:1e abbreviation PFA'refers to :pentagastrin fast ach.lorhydr.i.a ,
,n.1.ere t~1.e actua'l output was not measured but t21.e p:: fell be-
10iL 3 the C01Ui'11Yl s irapl.y refers to acid. b,ging present. In table
23 the abbreviation alk phos is used for alk8line phosphatase, the
value being in international units per willilitre, and the
abbreviations _::"'3T and ""IT 2,re for aspartat.e t ransanrinaee and
a'Lan i.ne transaminase respectively, both values being in international
units per litre • T.le abbr:7iations ill for morrth and y for year are
used to Lnd.i.ca't.a the durat.Lon of t i.me of treatment in the
appropriate tables.
- 1;? -
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TFIJiX3FORT OF VIT."JHn B1?
'I'h.is c':1;-;.l)ter is devoted to an historical review of
the liter~ture on trsnscooalamin studies. T~e review is
an attempt to provide the background to the work which will
be described in later chapters. In this introducto~r section
a great deal of emphasf.s will be laid on the different
separation methods used by different groups of workers, as the
accunulation of Y~~owledge has oeen dependent on, and often
confused by, this variety of methods. Tl1e review also attempts
to clarify how the current concepts of the transport of vitamin
B12 in plasma in man have evolved.
It is co~~on in biologic~l systems for specific proteins to
be involved in the trans}Jort of essential molecules. Th.e first
evidence that vitamin E12 was oound to protein came when Ross (1)
reported that heat treatment of serum was necessary to release
vitaroin 312 for microbiological assay. Faper electrophoresis
of serum f'ol Lowed by microbiological assay of sections of the
strips, s':1owed that the endogenous vita~in E12 in serw~ was
located in the alpha globulin fn.ction only. This ooseT'Tation
led Iit.ney et 8.1 (2)' to po s tuLate the existence of a specific
- 11\. -
serum 312 carrier protein. ~ley observed that this carrier
protein had only a limited ca~8,city to bind vitamin 1312.
Later studies by :;,~endelsohn et a.I \ 3) confirmed these findings.
j',liller and JulliYan. (4) showed that although the native
vi t3-J.-nin 312 was bound to an alpha globulin protein t any radio-
active vitamin 312 which was added to the serlli~ was pre-
dOJlinantl~l a s s o c i a t ed w.i tll ano the r fraction.. TCley S81J:i Y8.,t e d
the serw~ by starch gel electrophoresis and found that the
native vitamin :312 migrated to the anode but most of the
60ac'.31ed·· Co labelled 312 nigrated to the cathode. T:J.is radio-
active vitamin 1312 was detected in spite of dialysis t which
sug~ested that it was associated with a."1other protein. It
was concluded from these experiments that at the levels
of vita~n 312 present in nOrdal serQ~, the 312 binding protein
was almost saturated and that the addition of flITther vitamin
resulted in the excess being bound to other serum proteins.
It is worth stating at this point that whereas the
work carried out by Roes , by Pi t'ney et a l , and by:Menclelsohn
et al depended on microbiological assay to r..etect vit~~in 1312
later studies made use of radioactive forms of the vit~~n.
Three f'o rms of radioactive cyanocob?lamin Toere 8.Yail?~1)le:
57 58Co 1312 and the less frequently used Co
r:o
1312 C'J1d" Co 1312.
Cne or more of these isotopes could be introduced either in
vivo (oy oral or parenteral administration) or it could be
- 1'5 -
added to a ss'mple of serum or plasma in vitro: 'E.'1e dis-
trioution of the radioactivity in the s~~ple was used to
indicate t~e presence of the added vitaITin 312.
The first indication that more than one snecific vitamin
312 binding protein existed in plasma came from in vivo studies
by::18-11 and Finkler (5). They observed that v.ibami.n :812
was boruld by more th2~ one portion of a plasma sample which
had been fractionated with 8.J.ili~oni~~ sulphate. ~~e radio-
active vitamin 312 was cleared from the different plasma fractions
at different rates and this was attributed to the presence of
more than one vita~in 312 binding protein. Hall ~~d Fi~~ler (6)
separated a second 312 binding protein from the carrier located
in the alpha-l globulin region on a diethylaminoethyl-cellulose
(D~AE-cellulose) ~nion exchange collli0.n. Tney noted that this
second binding protein, which they christened the 110 component,
b01.L"'1d t~le major par-t of any vi t.ami.n 1312 added to the serum in
vitro. T~e other protein which they n8.J.0.ed the 210 component and
whi ch corresponded to the alpha globulin binder described
earlier, bound only a small amount of added ]12. In a later
study by Hall and Finkl~r (7) the 210 component was ren8.J.0.ed
tr2~seobalamin 1 (TOr) and the 110 component renamed trans-
cobalamin II (~CT.I) and this is the terminology which has been
generally adoIlted.
The separation of the transcobalamins was studied by Hom
et a1 (8) using a variety of technioues. Tney found that two
- 16 -
vit8Ain B12 binding proteins could be seplrated from each
other on carbox;ymethyl - 3ephs-dex (C};, -Sephadex), on
~recipitation in additio~ to the D~k~ - cellulose technique
already described by Hall and ?in.1z1er (6). T:.'1e C-200
separation also gave information on the molecular weights
of the two proteins, these being estimated at approximately
121,000 (TCl) and 36,000 (TCll). 3ach analytical method
yielded two fractions in which radioactive 312 was detected.
It was assumed" that the two fractions yielded by one method
corresponded to the two yielded by another and that they were
due to the complete separation of two vitamin 312 binding
proteins. TQis assQ~ption confused the issue for some time.
Studies by Lawrence (9) using zone electrophoresis showed
that vitamin 312 appeared to be bo~~d by three fractions in
aerum : an alpha-l globulin and a beta globulin (Which correspond
to Tel and TCll respeetively) and also by a binder with
alpha-2 globulin mobility. T-'1e presence of a third vitamin
:B12 binding protein in serum was also postulated by :tall and
Fin.1zler (10) when they added Co 57 312 to ser~ in vitro and
noted that the second radioactivity pe~1z which eluted from a
DEAE-ce1lulose colTh~n did not appear to be homogeneous.
- 17 -
In retros:;;ect this ooserv'"-tion ',78.S p.robab'ly due to 2Jl ar-t ef'act
Droduced by t~1.e se:;Jar"tion tec2'mique, possibly relcded to the
presence of heylrin, for the ls-ter work (11) has shown that
the second radioactivity pe?~ eluted frow D3AS-cellulose
contains only one vitauin ]12 binding protein. The de-
monstration by Hom (12) that Tell could form cO'7lplexes and.
bind to G - 200 at low ionic strength further complicated the
picture as it became apparent that this new binding protein
could be a polywer of TCll. Gizis et '11 \ 13) also demon-
st:r2:C2d a third binder when they separated the transco'bg,lamins
on DEAE-cellulose ond then checked the two fractions for
homogeneity on :::3epl-101ex G - 200. The 'TC11' fraction eluted
from G - 200 as a homogeneous peak (corresponding to a protein
w.i th a molecular weight of 40,000) but the TCI f rao t.ion
obtained from two radioactivity De?~S on G - 200
the major one at a Large moLecul ar- weight and a sma'Lle'r binder
wh.ich accounted for almost 335:, of the eluted radioactiyi ty.
Z1.ey attributed this to Tell contamination.
Simi12.r work waS undertaken by Lawr-ence \ 11) when she com-
pared the two binders separated by TIE}L~-cellulose with the
two separated on G - 200. Normal S8rlliu was shown to contain
three binders : a high molecular weight alpha - 1 globulin
(TCl) and a high and a low molecular weight beta globulin
(the new binder and TCll respectively). ~~e high molecular
weight beta globulin binder ap~ears to correspond to the yrotein
- 12 -
., • 1 -r- -.. " • 1 ( '"') 1 . .e-' ,
'?,:llC:l r.awrence :1.8.Q :r::rreVlous_y ') C as·Sl.Llen as an slpha 2
r;lobulin b.i nd er , 3he demonstrated the presence of three
binders by removing the low molecular weight protein (TC11)
f rom the se:cum "by 'lcsorption on to uncoa.t sd charcoal and
sep8rating the reT"ls.ining fraction on,:t D3A"2-cellulose co Lunn ,
TIiO peg};:s of vitamin B12 hinding- protein were still eluted
from the collwill although the first pe~~ was smaller than in
comparable experiments Th1en uncoated charcoal absorption was
not used.
~~e position was finally clarified hy Eloomfield and
Scott (14) who confirmed the presence of a third binder as
described earlier by L8~rence. TI~ey fractionated a serum
s arnp'Le on 2. D3AS-cellulose ooLumn and found 92:' of the
adiled ra·:::'io;wtiYity eluted with TC11 and 8/ eluted with TC1
wb e rea... s G - 200 se}j::lr2,tion of ~lnother sFtmple of the same s e rum
showed that 7f/' of the added ac t i vity eluted with TCll arid 2e
eluted with TC1. The discrepancy between the results obtained
from the two different methods '.'78-3 a.ttributed to the presence of
a thirc_ binder whI ch eluted with TC11 from DEAE-cellulose and
with TC1 from 3ephadex G - 200. ~ne third binder, ~~ich they
named Te111, flas fOQnd in fifty normal serum s~~ples and was
therefore not a pathological binder.
The properties of the third binder have been studied by
several groups. Eloomfield and Scott (15) showed that in the
absence of TC11, Tel11 had a gre~ter affinity for 312 than Te1,
19
and t~~t although it eluted fro~ ~3AS-cellulosewith TCll,
by v'lrying the conditions it was shown to be less fir:'11y held
on the ion-exchange resin. In an in vivo study, Ch~n~rin
et 8,1 (16) examined the possibility that a protein wh.i ch they
c'llled binder 111 (and which appears to correspond to TClll)
was a ]olymer of TCll. They sep~rated the three transcobala"lins
on a :DE.U-cellulose coLumn followed by G - 200 fractionation of
the TCll + binder 111 peak, and showed that all three binders
took up cyanocobal~~in from the gut simultaneously, in pro-
portions depending on their unsaturated B12 binding capacities
at the time. L~ey were 'unable to co~~ent on the nature of the
third binder' and on whether or not it was a poLyrne r of TC11.
Carmel (17) showed that the third binder, which is present in
small amounts in normal ser~~, is responsible for the elevated
Qnsaturated B12 binding capacity (UBBC) observed in the serwll
of patients w.i t~1. 1 eukocytosis. He compar-ed the binder with one
found previously only in the serum of patients with poly-
\
cythaemi.a rubra vera (described by Hall and Fin.'der (18) and
suggested that the two were identical.
IIT~unological studies showed that the third binder was
precipitated by anti-sera reacting with TCl (17, 19). England
et al showed by iwuQnodiffusion that both TC1 and binder 111 gave
reactions of identi t~· wi tll antiserum raised. to saliY?~ry R binder~
and f'r-om that d.educed that TCl and binder 111 were both circulating
R binders and therefore closely related. Tne term 3 hinder had
- 20 -
been introduced by Grssceck et al (21) to describe the non-
intrinsic factor vitamin B12 binding ~rotein found in gastric
juice. ~~e nrtme was derived from the characteristic rapid
mobility of the protein compared with the mobility of intrinsic
factor. (Intrinsic factor is the vitaMin E12 binding protein
concerned specifically with acsorption from the ~~t.) Lfure
recently the use of the term R binder has been extended to
describe all the vitamin B12 binding proteins %1ich have rapid
electrophoretic mobility, regardless of the body fluid in which
they are found, thus covering all the specific B12 binding
proteins apart from TC11 and intrinsic factor.
Sten~an has recently used isoelectric focusing to separate
the transcobalamins from each other (22, 23). He renamed the
R bindeTs 'cobalophilin' in order to avoid the implication of
rapid mocility, as the R binders obtained from different cody
fluids have electrophoretic mobilities varying from alpha to
beta (23). 3teJ:1J11an characterised the cobalophilin from different
sources (22, 23) and found it to be c. "microheterogeneous
mixture" consisting of five or more isoproteins with isoelectric
points (pI) between 2.3 and 5.0. He found that the cobalophilin
from different cells and fluids consisted mainly of the s~~e
isoproteins in different proportions. Tae isoproteins were
divided into two populations, one pi 2.3 - 4.2 and the other
pl 4.0 - 5.0. TC11 ~ad a pI value of 8xound 6 and therefore
did ~ot overlap wit~ the cobalonhilin isoproteins. It was
- 21 -
suggested (22) that t1:1ese 78Ti8,tions in t1:1e patterns of iso-
proteins present could accoQ~t for the differenct electrophoretic
f:lobilities ascr i.bed to the R binders, and for the d.escri:ption
of TCl as an alpha - 1 globulin and TClll as having a'Lpha. - 2
and beta mobility.
Addi t Lons.I vi t ami.n B12 binding' proteins h ave been observed
in the S8:r-U1TI of patients wi, t~1 clinical abno rma'Li. ties. One. such
b.i.nder , the FV binder, ',12S found by =-:a1l and Finkler (18, 24)
in the blood of eight patients with polycythaemi?. vera in
relapse. Tne protein reacted with anti - TCI and anti-salivary
R anti-sera but differed from TCl in its electrophoretic mobility.
Cn the basis on Ste~~an's classification the observation can be
attributed to a distribution of the cobalophilin isoproteins
different from that fOU:r1.d in normal serum. The foetal binder
described by Kumento (25) as eluting from 3eph.<3,dex G 200 with
TCl but having a different electrophoretic mobility is presumably
also due to a variation in the cobalophilin isoprotein pattern.
Affinity chromatography has been used to isolate two vit2l!1in
B12 binding proteins from serum. Tne separation of TCll in a
homogeneous form resulted in a two million fold purification
relative to human plasma (26). ~~e plasma content of Tell
has been estimated to be 25 yg TCll/litre of plasma (27) with
8. binding capacity of almost 1000 ng B12/litre of plas'TI.a (28).
~~e isolation of nure TCll allowed its properties to be studied (2().
The molecular weight as determined by sedimentation equilibrium
ultracentrifugation W8,S 53,900 and bySephadex G - 150 gel
filtration T<as 60,000. ~odilli~ dodecyl sulph~te rolyac~ylamide gel
- 22 -
electro~horesis showed that two ~e~tid8s were ~re3ent. From
this it -,\'2.3 inferre::1 th'lt the -protein was a dimer and that
it consisted of one suburu t with a molecular weight of 25,000
and another w.i tll a moLecuLar- weight of 38,000. Pur-e T011 "as
ab.l .\. bi.nd 2C\'< D" -::<12/"''''' of t· d thO bi d" Tc. _e co v.J.. ~.'-' fa -.; 'c pro ea.n an lS 'In z.ng 0_
vit~~in 312 by ~C11 shifted the pe~~ of ]12 absorption from
361 n~ to 364 n~.
A vit~~in ]12 binding protein was also isolated from the
granulocytes of patients with chronic granulocytic leukaemia1
using affinity chromatogra~hy as the sole purification technique
(29). A homogeneous protein ~as octaine~ from 9,800 fold
purification, and its mo Lecu'l.ar- v;eight '!l8.S f'ound to be 56,000
as determined b~r sedimentation equilibrium ultracentrifugation
arid 58,200 as determined by amino acid. and carbohydrq,te ana.Lysi.s ,
The pro t.ei.n had a.high carbohydr8.te content (33() wh.i.ch accourrbs
for the high molecular 1,'reight values (121,000 to 138,000) 'which
have been reported for the R binders when separated by gel
fil tration. 1".'1e granulocyte vi t.arai,n ]12 binding protein had a
single cobalamin binding site and bound 3<1..9 r g vi ta;llin :B12/mg
of protein. No shift in the vi talnin :812 absorption peak was
observed on its binding to the R protein.
Immunological studies using crude or ~arti~lly purified
proteins have sho~TI that the vita~in B12 binding proteins
fOUXlQ in human body fluids C&'1 be divided into three distinct
:'V t,inr'Jer, f'o e t a'l binder, the cr:o.::l1.1.1ocyte bineer, sa'lLvar-y binder
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and others). No cross-reactivi ty has "been f'ound oetvl'een the
three sTOUpS (30). V,=,-riations in the sialic aci.d content
of the ~ proteins are pro"ba"bly responsible for the hetero-
g;enei ty observed by 3tenlnan during' isoelectric focusing,
since treat~ent with sialidase appears to reduce this hete~o-
geneity.
In studies using serQ~ labelled with 57 Co 312 added in
in fractions other than those corresponding to the -vitamin
312 '\... .:J' n- r te' s 1 0 d .... , .."'" ~ 4" 57 Co 312. ui.no i. '" p 0 In a.ireac -:.T men caonec., "'cLen an excess or
was add.ed , four peaks of radioactivi t~l were detected (2.3).,
The fi:rst peak~ named TeO by =-{om and Ahluwalia was eluted at
the same ti~e as the first protein peaz. ~~is protein was
consistently found in G - 200 fractionation as a -vit2.min E12
binder over the range of 75 to 20,760 ng 312 added/litre of serum•
.Uthough Tee accounted for up to 5.2; of the unsaturated 312
binding capacity the protein has never been studied in ~~y
detail. One explanation for its occurence suggested by ~on
and ;~luwalia was that TCO is a complex of Tell, similar to
the complex formed in low ionic strength buffer. The second
and third peaks of radioactivity noted by Hom and .~~luwalia (22)
corresponded to TCI and TeIII as discussed above. The fourth
peak of radioactivity eluted from the col~n was attributed to
"non-protein bound 57 Co B12 and 57 Co not associatecl with vita..'11in
J312". This free 57 Co was ascribed to radiochemical inpurities
in the isotope preparation and not to disintegration durin5 gel
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fil t.r-a.ti on, In a similar s tudy :1"'.11 and ?inkler (10) added
large amount.s of vitamin 312 to s e'rum in vitro and observed
that the excess 1312 did not re;'lain free but was bound by
proteins other that TC1 and TC11. T.~ese binders were con-
sidered to be seconda~T or ~on-specific binders. A seconda~
binder was 8~SO described by Gizis et a1 (31) as eluting fro~
D3A:=;:;-cellulose with O.1E sodium 3lhosphate huffer. The binder
was only f'ound when large amounts of vitamin 312 were a,d.ded
to the serum (at least 300 ng B12/1itre vf serwq) and the
3lercenta,ge of the a.ctivi ty which it bound was increased as the
mass of vita.rnin 1312 added to the serum was increased. I t would
appear that this secondary binding is v.ery 'loose' and that
although it is able to survive D~Al~-cellulose fractionation
the binding does not withstand gel filtration.
It is evident from the nUdber of artefacts of separation
which have been clescribed t112.t care is ne ed ed in interpreting
any results which appear to suggest that a new vitamin 312
binding :protein is :present. TC11 in particular appear's to be a
very labile protein, comp'Lexf.ng y;ith itself and oincling to
.3ephadex G - 200 in the presence of low ionic strength buffers (12)
and also forwing complexes with heparin. Hep~rin is a strong
caticn exch~nger and therefore it is able to bind TC11 which
has a strong affinity for the cation exch~nge resin carooxymethyl-
cellulose. ~{eparin also affects the elution of tie vi te,D"in
:812 binding proteins from J)}~AS-cellul03e : S'C11 and binder 111
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are no lon?;er eluted ,,-i th phosIJ;''late 'buf'f'er but FJith IIor. ="aOl
solution .i , e at the same time 2.S TC1 (20). It is possible
that it 7i8,S this effect of heparin wni.ch was observed by
~all ~~d Finkler (10) when they descrioed the heterogeneity
of the TC1 peak eluted from TIEAZ-cellulose. In vitro studies
( 20) have also shown that the properties of TC11 and b.iride:r
111 8.:r8 2,,1 terad. f'o I'low.ing C; - 200 sep8.:r:--ttion; t~'"l-? elu.tec.
binders have a decreased affinity for vitamin 1312, &~d TC1
and binder 111 CP",,-"l no longer be separated on DEAZ-cellulose.
Sthylenedia~inetetra-aceticacid (ZDTA) also affects the
properties of the transcoba18ITins. In the presence of EDTA
57
more • 'Co 131';" eluted at the peak corresponding to, TC11 on
3ephadex G - 200 than when no EDTA was present. The 8xIJ12~ation
which was proposed for this o03e~ration (32) was that TC11 is
present in serum as a complex held together by bivalent
catior~c bridging. In the presence of EDTA the cations are
lh"lavailaole and TC11 does not associate.
Information on the role of the transcobalaoins in the
tr~"lsport of vitamin 1312 in the oloodstre2~ has come from studies
following the a~~nistration of radioactive 1312 either orally
or parenter8~ly. ~all &~d Finkler (5) observed that there
was a difference in the rate of clearance of the 570 0 cyanocobalamin
from the fr2ctions corresponding to the t710 transcoba.Larn.i.ns ,
r:.7Tney gave ~'Co1312 to volunteers, both orally and intraveneously
and observed that -the vi t.ami.n B12 was initially se'l.ec t i.ve Iy Gound
to TC11 (7). 'I'he rac.i02.ctivi ty was r3.:pidly cleared from TC11 and
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re-a:9::eared bound. to TC1, in amounts whi ch increased for
the first twenty-four hours. ?nis rapid clearance of
'1'C11 bound 312 ?as also obsel~Ted by ~om (33) ~~en he
injected a TC11 S7- J Co B1? com~lex into volunteers and showed
that only 32. of the dose was still present at 10 ~inutes
Y03t-i~jectio~. ~e detected 57Co E12 bound to '1'C1 at
4 - 3 hours, and by twenty four hours observed that all the
radio~ctivitywas bound to TC1.
A different theory for the roles of the transcobalamins
was proposed. by Chanarin et a1 (16) when they attempted to
elucid2te a role for binder 111 in the transport of vitamin
312. Tfley observed that an oral dose of 57 Co B12 was bound
by all three transcobala"Tlins simultaneously and suggested
that this bind.ing was in proportion to the ur~saturated B12
binding c~p~cities of the proteins at that In a further
study b;y the same group (20), 57Co B12 was obsarved to be still
bound to TC11 at 8 - 10 d8~s after oral a~ministration. T~e
theories which have been suggested for the roles of the
transcoba,lp.01ins in 312 tr?_nsport are di'scussed in greater
detail in later chapters.
Information about vitamin 312 transport proteins has also
come from studies of patients with an inherited deficiency of
one of the bind.ers. These cases are extremely rare, however,
only one family has been d.escribed as haying members wath 8,
TC1 deficienc~r (3~~) and on'Ly two cases of f'ami.Lies with '1'C11
deficiencies have been reported (35, 36).
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Tne only significant clinical abn8l~ality observed in
either of the two brothers who had the alpha - 1 globulin
(TC1) defect was a low se~~ vitamin 312 level. Sepa.ration
of serum sampLea hy starch gel electrophoresis and by rapid
DEA~~celh1.1ose arrion exch3.~'lge chro:n3,togre.phy showed that
there was virtually no Te1 present. Le~~ocyte extracts
and saliva samples from both SUbjects also yielded virtually
no vitamin B12 binding capacity. It must be amphae.is ed tint
although the brothers appeared to lack all R binders there
was no evidence of any metabolic B12 deficiency and the abilit~l
of tissues to store J312 was not impaired.
In contrast to the clinical normality of these two brothers
the cases of TC11 deficiency which have been described show
very m8.rked symptoms of severe vitamin 1312 deficiency~ in spite
of no rma'I s erum 312 levels. In both of the fa~ilies described
complete remission W8,S achieved 'by the administr::d;ion of large
amourrt s of vit2-min 312 to t:1.8 affected infants. The y,ithdr2-wal
of.ther~py led to a ra~id relapse. TI1e separ~tion by D3A~-
cellulose c~ro~atography ~~d polyacry19mide gel electrophoresis
of serlli~ samples from one family (35) and by polyacrylamide gel
electrophoresis of serum from the other (36) showed that there
was no '1'C11 present. In the case of t~e latter f~~ily this was
confi.rraed by experim.ents with anti - Te11 arrt.Lse.rum, Tile resuonse
to massive amounts of vitamin 312 could he due to the existence
of secondary or non-specific B12 binders, to diffusion, or as has
- 28 -
been :proposed by =-{i tzig et al (36) to t~e a:ppear2.nce of a new
312 binder 7;i th alpha - 2 electrop:'1oretic mohili ty similar to
TC111 and f'oe t a], hino.er. TDe inf3.nt described by Hitzig et al
was unanLe to s~mthesise immunoglobulins :prior to 312 therapy
but this defect of the i~~une system W'lS corrected after treatment
T~e sic~ificance of t~is finding is not yet kno~~.
Alt~ough the two groups of serum B12 binding proteins
have been studied in some detail the terminology used still
gives rise to some confusion. In add.i tion to the nornancLa"VJT e
~~lic~ has been described, other workers have given the
trsn.scobo:tlamins alternative n8JT1.es e.g. TC.3, S:CL, ::lEI' and L3:2
as suggested by Gullberg (37, 33). In the work to be described
it is proposed to retain t~e term TC11 and to use TC1 + 111 to
describe t~e R binders present in serQ~. T~e 'i'CC binder has
been considered se:pars,tely in the in vi t.ro experiments as
there is no information yet on '"hether it is a TC11 comp.lex or
should be regarded as an P. binder.
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=I '111 and ?in-l:ler (C \,\. V j
:raIl and Finkler (7)
Grasbeck et al (21)
Stenlna..n. (2;2)
Gullberg (37)
Gullberg (38)
Table 1
rrC1 + 111
210 cO'":1yonent
Tel
R binders
cobalophilin
TeL
LBP
Tr'lnscoba.Lami,n
110 comporien t
TC11
SBP
HO!'lenclature
zone electrophoresis pH 8.6 (9,11)
DEAE-cellulose elution (14)
TC1
e<.,
Th1 NaCl
TC111
c:;{::>. (~
phosphate buffer
TC11
P
phosphat e buffer
G-200 elution (8)
CM-Sephadex elution (8)
CM-cellulose elution (27)
.i ao electric point (23)
st arch block electrophoresis pH 4·5 (27)
adsorption lW uncoated charcoal (11)
ro].e in :812 transport (27)
(:rm
4
) 23°4 precipit ation (8)
c~lrbobydr8.te content
moIocu.I ar "Ieiebt
no of sulmnit s
no of b i.ndLng sites
amount of :812 bound ( pg E12/mg protein)
B12 absorIJtion peak shift on binding
site of synthesis
I' e act ion 1'lit h
i) ant i R (30)
ii} anti TC1 (30)
iii) ant i TC11 (3 0 )
promotes UIJtalee of 1312
by i) Hela cells (27)
ii) ret iculocytes (41)
plasma content ( pes protein/litre) (27)
tot 8.1 bind ing capacity ( ng El2/1itre plasma) (27)
approx. %saturation (27)
TC1 & 111
mol 1-rt 121,000
early
early
2.3 - 5.0
anOdal
no
binds endogenous :812
2.5 - 3.5 M
33% (29)
ar au nd 55,000 (29)
l( 29)
l( 29)
34.9 (29)
No( 29)
granulocytes (39,42)
+
+
no
no
60
700 - 800
50%
'rC11
mol vrt 36,000
Lat e
late
6
c at hodol
yes
binds newly absorbed :812
1.5 - 2.3 M
none (26)
around 55,000 (26)
2( 26)
l( 26)
28,,{) (26)
Yos( 26)
liver (41)
....
+
yes
yes
25
986
2%
Table 2 show Lng d Lf fer-ence s in the properties of the transcobalamins.
c ~ APT E?c 1
'L-lE .AJ?:F'LICATION" OF 'LiE OCCUFANC'(
F?cPJCIFLE TO IN VIVO :3?U:DI83 0;
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3;'JCTICl~ 1
'r({~ cCCiIFAI'~CY FRHrCIFLS
~~e occupancy principle provides a me~~s of relating the flow
of a sues -'~,',;mce into a system with its capacity and oc cup ancy ,
Tne foundation of the theory was described by Bersner (43 - d7)
and it was pro;JolElced in a f'or-n 8.p:;Jlicable to the anaLys Ls of
radionuclide kinetic data by Orr and Gillespie (~8). ~e
principle has been utilised in studies of th~~0xine secretion
(49), iron met8~olism (50), calciw~ absorption (51), t~yroid
io8~ne content estimation (52) and drug dos?~e studies (53 - 55),
but it has never been applied to the p.nalysis of the data obtained
using rcidioactive vi tamin J312.
~~e occup~~cy principle is the main analytical method used
in the studies described in this chapter and therefore it is
appropriate to restate the essentials of the principle with
particular reference to the metabolism of vita~in ]312.
TIle application of the occupancy principle to kinetic
stadies of vitamin ]12 metabolism reQuires certain assQ~utions
to be made. Firstly it is assQ~ed that the radioactive vitamin
]312 (in this case 57 Co cyancoba'lami.n ) is a true tracer, that
is, it is treated throughout the system in the same way as the
non-radioactive vita~in B12 which has co~e from the diet.
Cyanocobal&~in is not a naturally occurringfo~ of the vitamin,
either in food (56) or in human tissue (57) but there is evidence
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that it is r8.pidly comrerted to biological forms (57). A
second requirement for the app l ica.t.i.cn of t':1e occupancy principle
is that the system is in a steady state, that is, the entry flow
to any compar-tment. is ba'l ariced by the exit f'Low and 'thus the
amount of suostRnce in 8.ny compartment is constsnt. It
follo'i7s from this that the flow throug':1 the system is also
cons t.arrt , Small vqri~tions in t~e input flow, represented
oy variations in the diet2TY intake, can h07'.'eyer be neglected
because the bo dv turnoyer time for v.i t ami.n :212 is 10!1f:. The
final re~uirement for the application of the occupancy principle
is that the tracer material is introduced into the flon which
is to oe measured.
~~e salient features of vitamin B12 metaoolism are re-
presented schematically in figure 1 (8.). The dietary intake
is represented as F~ which, since the system is in a steady state,
.J.
. 1 t th of tl1R D 1 ~. = ~ ~ .lS equa 0 ,e SUITl ,.L • _ r ae ca excre ci.on ""F ann "De uri.naz-y
excretion Only a part (FA) of the total flow is aosorbed
and t':1.is constitutes the entry f'Low into plqsma. The rem2_incler,
ED' is excreted directly as R. comporien t of the faecal excretion ~.
Cf the amount which is excreted into oile, a part Cpu) is
"'.
reabsoroed, and the remainder (~) contributes to the total
~L
faecal excretion En.
l'
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Figure 18.) A aohemat.i c r. i8.f;r2,m of the essential features
of vita:rti~ B12 absorption.
'I'~e neriva.tiotl of the Occu:P8.Ilcy ::rincilJle
It is as'~1.J.!:1(~c1 t,rnt 2. boLus of radioactive tracer is
introduced inst~ntaneously into t~e input flow to a system
at time t = O. At time t later, a fraction fi of the tracer
will be in a particular part i of t~e system. ~~e value of
I.1. a t any... })8.rticula.r tiDe t is c.enoted 8~S Ii (t).
At the time of the injection t~ere is obviously none of
the tracer in part i. The fraction rises to a maximum, different
for each p"trt of the system, as the tracer is carried into eac'c1
part by the flow of stable material. TDe fraction then falls
to zero as all the tracer is carried out of that part. It is
a s sumad that the tracer is tre9.ted in exactly the same way as
the stable material. Clearly, ty the time all the tracer has
been removed from the part, all the stable m"tteri9.1 which entered
the system before the injection of the tracer will also have
been carried out of the part in quest.i.on, In other words, the
total content of stable material in that part, called its
capacity, is made up of material which entered the system after
the tracer injection. Since the input flow, F, is constant,
in any short time ~t an amount ?St of material enters the system.
Tracer and stable material behave in the same way so an amount
F~t.fi (t) of this ~aterial will be present in part i at time
t l<:<ter. The tot".l amount of stable materi8.1 in part i is,
therefore, made up of all t1.1.o.se elem.enta:ry contributions from
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the ti~e of injection of the tracer Q~til the ti~e when tracer
activity in the yart i has fallen to zero. To be strictly
correct this latter tine is reyresented ~s infinity. Tnus,
oapaci.iy Ci ~ ~~fi (i) dt ,
The La t t er integral is teTI'led the occupancy of y8,rt ianel is
S 1-. l' d 1-. c:z:,.. -.J..'t· . 1 th 't' t""t j ....ymco a se oy o a . lS ea.mp y e ;=tree'. unner ne ac lVl YI t rme
curve for the part in question where activity at each time is
measured as a fraction of the total injected activity.
The extension to the real situation where the tracer is
not injected instantaneously is now straightforward. ~~e rate
of a~~inistration of the tracer is not imyortant, as the input
may be regarded as a series of instantaneous doses. Each
of these elementa~v doses will have the sane activity/time
curve in that part of the system of interest, out displaced
in time from the others. ~owever, it is only the area under the
totg,l act i vity/time curve that is required. This is 80u8.1 to
the sm11 of the areas under the elementary activity/time curves,
whatever their relative displacement in time. The derivation
above is thus valid whatever the time scale of adw~nistration
of the tracer. Different rates of admini~trationwill produce
actiVity/time curves of different shapes out of the same area.
T~us, the occupancy principle is obtained: (capacitY)i
equals flow x (occupancY)i for any part i of t~e systen. 3y
making serial activi ty m.easure~ents for any part and d.etermining
throu;::h the system may "be d.educed from the eClUatio:'1:
flow ( '" '" . t' T "\ cu.p._Cl .J J i
( occuP"J.nc'y, J .
" , / l
Thus, by mea.suring tne serum 312 level
and by making serial ac b.ivi ty measurements f'oLl owi.ng oral
of vitamin E12 may be obte-inee.. Furthermore, since the flow
is 2~ constant of the system the ratio of capaci ty to occupancy
for any :)Clrt a s the aame, :::
If the ra.tio of c'1pacity to occupancy for plasma is found as
800ve and whole body occupancy is deduced from serial whole
body activi ty measurements, the whole body capac.l ty of 1312 may
be est':'!'1ated.
The occupancy principle may be used to deduce either the
d.aily dietary Lrrtake of 312 or the abeo r bed flm'/ into plasma,
depending on whether the tracer is given orally or intravenously.
If the tracer is given orally then it is introduced into a flow
which is coming entirely from the outside and which includes
an unabsorbed component ~TI as well as the 'absorbed flow
Cn the other hand, intravenous aQministration of the tracer is
equivalent to introducing it into the entry f'Low into plasma
since there is rapid mixing and all points of introduction into
plasma are equivalent. The flow that is measured is then the
diet;:n:; absorption?, only and the recircu13.tion is not included •
.'t
This point is m~de cle~rer oy redr~Ning the relevant p~rt of
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the s chena't.i c a.i::Jgrs.m as in Figure 1 ('0). The recircul,~tion
flow FD is separated from the diet~ry ahsorption flow F.l~ ~
which is the only floh entirely from outside this particular
svs tem, 'I':1.e recircul","tion is now seen as something totally
within the system "being considered. As such it will not "be
revealed by application of the occupancy principle to
the system in 7i~~re 1 (b) followinGintravenou3 addinistration
of the tracer.
It was assumed that the injected. tracer mixes rapidly
with the stable B12 and is tre~ted in the same w~y as :812 newly
~bSOTb~d from the gut. It therefore follows that the area
under a plC?sma activity/time curve for un i t act.Lvj ty entering
the plasma will be the s~~e, 7~lether it enters directly by
injection or indirectly from the gut. Since the activity/time
curves of a.ll units of actiYity entering the plasma. are
additive the total are2- under a measured plasma activity/time
curve would be proportional to the total activity entering
plasma. In the case of intravenous injection of tracer
100. of the activity enters the plasma, whe.reas with oraL
administration only the absorbed fraction enters the plasma.
The ratio between the plasma occupancies in the two cases is
therefore equal to the fractional intestinal aosorption of
vitamin 312. TIle capacity of the p'l asma does not change CL"1d
therefore it is possible to ca'Lcul at.e the two different f'Lows
the tot,,"l o.iet2x"y int;:J~e of B12 and t':le absor-pt i.on flow of
dietary 312.
TISSuE.
?igure 1':"')
n
"l. sc"hem;:ctic di8.-a.-raT'lJ. of the e s s en t i.a.L fe"dures
of vitamin B12 ?Dsoyption.
T'ne occupancy princiyle has a major advarrtage cver
ccmpar-tnerrca'L ana.Lys.i s (58) 3.S it does not aasume t.hat the
tracer is un.Lf'o.rmly distributed. '.vithin pools. This is often
not the C3.se and the pools are not necessa.rily physically
equ.i.va.Lerrt to 8.ny particul3.r organs. In the case of the
occupancy principle the T'1easurements are made on defined parts
of the eys t.em and therefor~ any ca.LcuLa t i oms rnad.e refer
unambi;uously to those parts. ~~e disadvantage of the OCCUP~"1cy
principle which it shar-es with all forms of exponential analysis,
is th,,"t -:neasurements have to l:)e made until the 3.ctivity in
the part of interest is effectively zero. In the case of
vita~n 312 with its long biological half-life these measureT'1ents
can be unduly protracted. However, after a long time has elapsed,
and when the tracer has fully equilibrated vii th the stg,ble material,
t ' ',.... It' '" . 1 t· l' ~tne aC1;;1.Vl ",y arne curve ne cornes a so.ng.i e exponen aa "c. 8
vii thee. being the fractional daily loss of stp.ble material. The
IJs. , '"?"rea to infinitv undar this t2.il is eoual to - wh.i ch is acHed
<J ~ <:>C.
to the directly compu.ted ar-ea under the earlier part of the
t · .... IJ.·ac lVlvy vlme CU~le.
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Irltroduction
It will be o'lear , from w~at has been s af.d in the previous
section, that the occupancy principle c~~ be used to obtain a
measurement of the plasma flow of vit~nin 312. ~~e term
'flow! is not one which is coamonly fOQDd in the literature
on vitamin :012 TIl et2~bolism but it may be equated VIi 'th the
terms 'need' and 'requiresent' which have been used to denote
the mass of vit8min :012 normally absorbed from the diet by
a healt:lrsubject. ~stimates of this need have been obtained
hef~re, but there is poor 8.freement between the results obtained
by the different methods. T~e study which is reported in
this section was undertaken in order to obtain estimates of
the daily need from data analysed by the occupancy principle.
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r-~1.tient Debils
Nineteen sUbjects took part in this study. They were
. , 57,., -,12glven 'vO D and their plasma activity was ~easured at
various tiDes thereafter. Nine of them had been treated
for vi t?-:"1in B12 deficiency for yeriocls ranging froB five months
to seventeen years. The nine had all oriGinally presented
with s~mptoms of a macrocytic anaemia, megaloblastic
e~ythropciasis and a low serQm vitamin B12 level ~~d all but
one (case 5 who had previously wldergone total gastrectomy)
h ad a ha s tami.ne or pentag;-wtrin f~,-st achLorhyd.r.ia; ~::one of
these patients cou.Ld absorb ora.Tly acl.'"'1i.nistered radioactive
cyanocobalamin normally but all did so when the dose was given
with a source of intrinsic factor. For the sake of brevity
this group of patients is subseQuently referred to as the
PA (pernicious .anaemi.a) group. ~';o patient in this group
received vita~n B12 therapy in the month before the studYJ
or, with one exception (case 3), during the study. A group
of ten patients who presented with various conditions, and who
1'1.8.de up a control group, were also studied. :Dete.ils of both
groups of subjects are given in tables 3 and 4.
The purpose and nature of the study was explained to all
the patients and their verbal and written consent was obtained.
Case
57Co B •No Age Sex Clinical st at e Hb B12 Dose anl route of 12
---
I 76 M PA. Treated 5 m 13 .9 1825 0.09 pg 15.0pCi IV.
2 68 M- Il 11 9 m 14.7 380 0.08 II 15.0 11 11
3 67 M 11: 11 11 in 14·9 200 0.12 II 15.0 11 11
4 69 M 11 11 14 y 14.4 240 0.09 11 15.0 II 11
5 65 F 11 11 17 y 12.2 520 0.12 II 15.0 11 II
6 57 F PAt 11 6 y 13 .9 120 0.10 II 15.0 11 oral (+IF)
7 66 M II 11 7 y 14.2 - 0.09 11 15.0 11 11 11
8 67 F II 11 . 9 Y 12.6 1000 0.09 11 15.0 11 11 11
9 72 M 11 11 12 Y 14·5 250 0.09 II 15.0 11 11 11
TableS: Sho\'1ing details of 'Pernicious Anaemia' group of patients.
Case
Dose and route of 57Co B1 2•No Age Sex Clinical St ate Hb B12 folate
g/dl ng/l ng/l
-
10 80 F CVA. Carcinoma colon 13.8 400
- 0.09 fg 15.0 r Ci oral
11 65 F Myocardial infarction 13.3 360 5·0 0.09 II 15.0 II II
12 88 F Peripheral vascular disease 9.8 280 3.2 0.10 II 15·0 II II
Myelofibrosis
13 81 F Duodenal ulcer 14.7 750 3·5 0.10 II 15.0 II II
14 52 F Secondary carcinomatosis 9·2 250 2.6 0.08 II 15.0 II IV
15 ,67 F Pancre at it is 12·7 250 - 0.08 II 15·0 II II
16 58 F Renal OaLcu'l LsPye Lonephr a't is 10.8 300 20.0 0.12 II :1:5.0 II II
17 72 F Ulcerat iva colitis 11·5 260
-
0.10 II 15·0 II II
18 63 F Myocardial infarct ion 11.0 140 'I'20.0 0.12 II 15.0 II II
Treated folate deficiency
19 59 F Chronic renal disease 9·9 400 6.0 0.11 II 15.0 II II
Table:4 Showing details of the 'Cantrall group of patients.
=-7The ./. Co 312 close was
r::71 ~ '-" )'C • 1 .
. J fVl ~, 0 cyano co oa.i arm.n ,
ccrrt.e.in.i.ng C. 08 to 0.12 YE::" of vi t.ami,n r=)12. 'Ih.i s dose WO.s
adrni.nts t e.red ei t:ler ora.L'Ly or .i.rrtravenoue'Ly , The radioactive
preparations were made up from sta~nda.rd solutions (s~ecific
Radiochemical Centre, ~~ersh~~. Z~e intravenous dose was
sterilised 'oy Hilli~ore filtration and given in a voIume
of 5 ml , The oz'aI d.ose was ma.de up to 100 ml " with water.
3amule collection
20 ml s~~ples of '01000. were obtained 'oy venepuncture
at intervals up to a :Tear after the ['"dministration of the
radi08.ctive vitamin 312. The blood was collected into clean,
but not sterile, gl::::",3s tubes and ,'la,s cerrtr.i f'uged w.i thLn three
hours of collection to separate the serQm. 5 ml . aliquots of
othe seru~ were stored in plastic tubes at -20 C.
3erlli~ vitamin 312 levels
3erQ~ B12 levels were determined by a microbiological
aSS3~ using Lactobacillus leichns~ii performed by the staff
of the J)epa.rtment of Haema'toLogy , 30uthern General ~-Iospit2.1,
Glasgmv.-\. standard of known vi ta..'11in :812 content was aeaayad
wi tIl each batch.
- ':\.0 -
~8.dioactivity me8.surement
?~any of t~e sa~ples contained Ye~r little r8.dioactivity,
so the f'o Llowd.ng methcd 718,S used to maxi.mt se the si,'illificEtnce
of' the courrt i.ng resul is. iGach serum. aamp l e (Yolu;ne 1 ml) was
al tern:::.ted with a backg.round sample of local tap wate r
aerum samp'Las and tap water s arnpl e s a standard was count ed ,
This standard contained either 0.00~ or 0.05: of the dose
administered to the patient~YJ.d was obtained from the s~ue
batch of isotope. ~~e radioactivity was measured in a re-
frigerated two channel ga.'Thu8. acarrt i.Tl at.Lon spectrometer
(Packard model No. 3002) with a 80(1iu'1l iodide well-type
. 1 '8.Lh' Ls . + r! t + t' 57,.., ' ... ~ 1-c.rys t a.i , _0 \.;1_ cnanne .:;, were ae t t o .;.9 e c t ne vO prio t.o peax ,
using a narrow window in order to mini~~se the backgroUQd
:::wtivit~f. A counting period of 5 minutes was chosen and the
b2.tch was re-cycled until each s~uple had been counted about
ten times. ~~e results were printed on a teletype 2.nd punched
on paper tape. In this wa-;l each sample and background was
counted for about 50 minutes in total. _~y errors due to changes
in cOlliYJ.ter efficiency or backgroll..YJ.d level could be eliminated
by using the background vaIues on eithe:r side of the sample.
The resulis mexe analysed f'rom the paper tape by 2, 'TarLm
620/L - 100 mini-computer. 3tatistical analysis of the approx-
ina,tel;! 150 5-minute c'J.ckgrouncl counts in each run showed ths-t
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on everf occasion the actual standard devi~tion was very
cLoseLy equal to the square root of the background count,
and that individual va.Lues were norrna'ILy distributed about
the me2~. No systematic variation in the hackground was
detected 2nd so the mean value was used for calculation
thrcaghout each run.
The appro:pri8,te 5-minute COlL'I1tS for each serum samp'Le
and for the standard were sumJ7led and the relevant total
background was derived as the product of the mean background
~'I1d the numher of times each sample was counted. Tnis total
backgro1.L~d value is subject to statistical variation ~ith a
standard deviation ecua'L to the square root of the numbe:r
of counts. Since the :probability of the backgro1.L~d differing
from the mean by two standard deviations is 1 in 20, any
total samp'l e count which exceeded the tot;l background by
less th8TI this amount was discarf3d as being totally in-
distinguishable from it.
Tnese :procedures were carried out for both the cOlli~ting
chan.Ylels, as they had slightly different counting efficiencies.
The two measurements of samp'l.e -activity 0 bt.a.i.ned howeve-r are not
st""tistic;;:,lly inde:pendent since, on the ·;....hole, t'rle same detector
:pulses ~re heing cOlli~ted by e~ch ch3nnel. ~~e only differences
are in the slightly different settings and in the st~tistic""l
fluctuations in the counting windows. To make s8:lsible use of
the slightly different results rro:TI the two channels the
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ave'rage voLue of the two final r-esu.l ts f'or aach sample was
obtained. Tnis final value was expressed as 2. percentage of the
administered dose per litre of sertm.
Results
It -"1'3,,'3 apparerrt from a plot of t:le se:!'1.L1Jl r-esu'l ts against
time of 10'S/linear [(rayh paper (for examples see Figure 2)
that the 57Co activity from day I to the end of the study
(about 300 days in the cases observed for the longest time)
could in ,c;eneral be described by a triple exponential function.
A( t ) +
The method of deriving- the parameters varied slightly wi t.h the
Quality of the actual data but fo:!' most cases the results from
about day 1L1 onwards we:!'e fitted to a double exponential curve.
Tne value of this function was calculated and the result
was subt:!'8.cted from the oose:!'Ved value at each of the earlier
times of me8.surement. These difference values were then fitted
to a single exponential curve, describing the early pnase of
pl.9.s"1<: . 2.ctivity
Both the single exponential and the double exponential
fitting routines used an iterative method to obtain a least
squares fit of the function to t':le actual data values rather than
the less accurate method of fitting the exponents to the
logarithms of the d~ta values. Tne fitting routines began
by deriving crude esti~ates of the required par3meters by
fi tUng the logarithms of the e?"rly and lste values to single
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Example of the fitted fQ~ction for case 1'7...
expcnen t i a'Ls , 'nth these va'lue s for the parameters, the sum of
the squares of t:'le differences be twe en each observed value and
that ca10ulated fro~ the eouation at each time was found. By
taking cIerivatives the initial vaIues of the pararne t er s were
all changed by a small amount in such a direction as to give
the gre<'_test reduction in this aum of aqua.res (""path of
steepest descent.") The sum of squares was recalculated for
the new values of the par~~eters and the process was iterated
until a further change of the p';trameters did not reduce the
sun of souare s significantly. The final vs.Iuas were printed
out as the "least scuar-es " vaLue s ,
The values of the parameters clescrioing the tot8.1 plasma
ac t i.va ty cur-res for 18 :patients are given in table 50 together
with the len~th of time over which the results used in their
derivation were obtained. Tne area under each activity/time
curve (the occupancy) may be ce.Lcu'Lated f'r-orn the p"',r:::_meters of
the triple (or in some cases double) exponential p2.r?_meters,
viz:
Area
In stating this equality it is assumed that the third ex::oonential
component represents the final rate of decline of the pl aema
ac't.ivi ty to negligiole va'l.ue s , 'I'he vaLues for the p'Lasma occupancy
for each patient (excent for those with too short a study period)
are ~iven in tahle 5.
- L1.1 -
c<. C<..2 ~Case study Time A 1 1- haIf- A 2 ha1f- A 3 3~ half- Occupancy
No ( days) (%/1 ) (d 1) life (d) (r~/1 ) life (d) (%/1) life (d)
r
1 1 - 28 1.3 .096 7·2
2 1 - 7 1.02 .12 5·9
3 1 - 325 1.26 .32 2.2 1.49 .061 11.4 .034 .0033 211 .389
4 1 - 238 ' 097 .41 1.7 .63 .090 7.7 0084 .0012 587 .800
5 2 - 321 ".54 .24 2·9 .720 .063 11.20 .033 .0023 307 .278
6 2 - 325 .31 1.10 .63 .26 .091 7.6 .028 .0027 260 .138
7 3 - 168 10.01 .25 2.8 .76 ~012 57
8 2 - 213 7.6 .38 1.82 ~38 .058 12 .068 00019 361 .622
9 3 - 84 .26 .26 2·7 .17 .012 58
10 3 - 84 ·55 .22 3.2 .23 .0022 321
12 1 - 84 .56 021 3: 03 .40 .028 25
13 1 -154 065 011 602 016 00058 120 0321
14 1 - 49 1.85 013 501 .31 0018 38
15 21 - 28 2.82 .41 1.7 1.12 .068 1002
16 1 - 262
·55 0:53 2U 062 .069 909 0037 00023 297 .263
17 1 - 140 3069 .16 4.3 017 00044 157 0621
18 1 - 67 .81 .50 1.4 1.11 .072 9·7 losing 'ileight
19 1 - 18 2·5 .96 .72 1.20 .048 14.4
Table 5: Showine results for in vivo plasma clearance studies
n a.Lf ha'l f half
Al life -"1.2 life A3 life occupancy
2,11 D:ctients 2.07 3.10 .70 ?~ .094 291 .429._ I
,j~,,~ 0.C3 0.45 .11 5 .025 45 .080
2,11 oral ,..... r '",- 2. S5 7,q 32 .12 • )c'{)~.OJ
·./-"
5~~::LI 1.5(· 0.65 .10 11 .05 53 .141
all I"\i 1.57 3.20 ·90 14 .072 312 .470
0_.::.i..~:. 0.31 0.63 .14 4 .026 74 .104
OT3,1 control 0.59 4.23 .40 25 .20 221 .321
3~'L 0.03 0.98 v- .035 101
ora'l, IJi 4.55 1 0'::' 3° 34 .O/}8 3'"'"' .380--././ · / I I
,-""j' • 2.5 r. ~r\ "'~ 1!L .020 51").::':';')l. V • ..JV • I)
I~J control z.oz 2.55 "7 16 10 227 • .142.OJ .
0~~~ZI: 0.49 0.71 •17 5 .07 70
IV ~, 1.01 3·98 .514 10 .05 3t8 .L~8J,j: ~.J-,-
'.)~;.!- 0.14 1.0:; .28 1 .017 113
showing the ?overage v-alues of the pST8Jneters
descri"bing' tob,l -p12,;3:11::1 8.ctivi ty curves.
."'.n estimate of the d?iTy f'Low of vi t.ami.n B12 was derived
from the (lata fror. the subjects who nad a fairly constant
s e run vitamin :B12 level. T."l.is estimate V1S-S a otained. from
the pl8.si'l'1. o ccu'oanci.e s wn.i.ch a:t'e relp.ted to f'Low by t?le
equation showTI earlier
occu-pancy 1~ "p asma
- 45 -
1. The -ol"',sma turrrover of' vit"'.!ilin B12
Previous descriptions of the disappearance of intr8~
ve~ously administered vitamin B12 suggested that there was a
rapid initial phase followed by a slower rate of turnover (59).
r",.dioactive vitamin B12 (60) suggested th8,t the bi.oIog.Lcs.L
half-life of B12 in pla.sma, was about t: da,ys ann this V725
confirmed ~s 5.14 ~~ys by Adams (61).
These results supgest -that only th,~ first two p':1.=J,ses of
the activity/time curve were obse~Ted. T~is is not surprising
for it was only in those subjects who were s tudLad for rnore
t~Hn twenty week:; that Po t~1ird axporierrti.a I could. be fitted to
the data points. Tne half-lives observed in the first PIld
second phases of t':1e function were 0.63 - 7.2 days
(mean = 3. 1 days) and 7.6 to 58 C18.:ys (mes,n = 20.9 days).
E~ollin et a'l (59) observed a deLayed cl earance of vitamin B12
from the plasma of subjects with untreated pernicious
anaemia. This difference was not apparent in the present study
becau.se the patients in the F'i group had 8.11 received trecdment
prior to the study.
- Lit -
2. T:.f1e flo';1 of vi t?n i n 131?
Estimates of the diet8.ry intake of vit;:Lmin 312 g8,ve
a measure of its flow into the body but not into plasma,
because only ;:L ~')roportion of t"le ingested. J312 is -9.bsorbed.
and of items of diet and have ranged from 0.7~g per day
(the minimum value f'cund by Feeley and ~Toyer (62)) to a
max.irnum value 0 f 31.6f' g per clay reI)Orted. by Chung et a1 (63).
The actua.L value was consid.ered. to be dependent on the cost
of the diet, protein content and natrrre of the proteins
present. The values quoted for fatty foods such as eggs and
milk may be underestimated because of the low recoveries of
312 from extraction prior to assay (sf). A.tl estimate of the
aver~se daily dietary absorption of vitamin 312 has also 'been
obtained from kinetic analysis (58) and a value of 1.22~
was suggested for people living on a ~estern diet.
gstimates of the flow of vitamin 312 have also been obtained
from studies of the daily loss. The amount of 312 €Xcrete0
could reasonably be taken to reflect the daily need, ·as this is
the amount of 312 whic''l must be repl:-wed to maintain body stores.
Three methods have been used to esti~~te the losses by excretion:
kinetic analysis, \fliole bocy monitoring and a theoretical
calc~lation based on the length of time
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to deplete
"body stores after total gastrectomy (64). The loss of radio-
active vit~~in B12 has been monitored over lengthy periods of
tine by two Groups of workers (65, 66). en the assQmption
of eouilibr'1tion the loss was found to correspond to 0.'1%
to 0.7 of hody stores per day. Translation of this
percentage into an absolute value reouires some knowledge of
2.5 mg. then the daily loss is of the order of 2.5 to S.0)1g
per day. The estimated loss by kinetic a~lysis (58) was
1.2yg per day. Grasbeck (64) a.ssumed that the 10s3 of 312
after total g:-:.strectomy could be described. by a single ex-
ponential f'unc t Lon, ':Ie observed that the mean time for
development of megaloblastic anaemia was four yee.rs aft er total
gastrectomy and asswued that this was due to depletion of the
body stores to about 10-' of the normal. ~~e ca'Lcu'l at.ed th3.t
this loss was 8.t a rate of 0.15 to 0.3: per day lihich is equa'I
to 6 - 12 f5 per day asslli~ing "body stores of A mg.
The daily rcwuirement for vitamin 312 1'18.s aLso "been
estimated by Sullivan and ~Ierbert (67). 'Ihey studied the amount
of parenter.3.1 vi t.ami.n B12 required to induce a remission in
patients with pernicious a~aemia. A value of 0.1 ,g per day
was suggested but ob j ec'bi on has "been made to this figure on
t~e grounds that if the daily need is related to the body stores
of 312, as suggested by Adams and Boddy (65), then the requirement
for 312 ';\Till be lower in a uatient wi tn pernicious anaemia in
- ,18 -
r-eLapse th;::m in a norma.I subject.
~ven making allowances for the fact that only a proportion
of t~e amount of vit?Ein 312 v.hich is ingested is absorbed,
there are obvious discrepancies between the estimates for
dietarJ intake and for the daily loss (or ~~ount required
for balance.) The results obtained from the present study,
although limited to seven of the subjects, range from 0.3 Jlg
per day to 2. 7 yg per day (see tabl e 7). The mean value
of the daily dietary flow (1.43 fg) as one would expect,
is higher than the mean value for the absorption flow (0.84 115
per day}, T.'1e ratio of these two figures sugs-ests that on average
::tpnroximately 59< of the da.iLy Lrrtaks of :812 is absorbed.
'This value accords well with what is known of the fractional
absorption of cyanocobalamin at a dose of 1~g (Quoted by
Chanar-i.n (68) at 56 ').
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Case .3ertlJD. 3eTIL'1l
Flow
Humber Route Cccun:mcy (8) C2,7)"',ci t:r
( r. \ (e-r-;/day)
\ oJ J
J
3 lIT .339 18t:
0.5
;1 IV .800 216 0.3
-r-
5 1"17 .2703 AbS 1.7_v
6 oral .138 149 1.1
8 oral .622 1700 2.7
13 oral .321 175 0.5
16 IV .263 347 1.3
17 IV .621 256 0.4
Table 7 The estimated flows of vit"1min ]312.
Introduction
Although there is agreement that the transcobal~nins
are specific carrier proteins for vit~~in ]312 there is some
doubt about the precise role of each tr~~scobalarr~n in the
met"l.bolism of ,rit;;>-e'"'1in ]312. In an attempt to resolve this point
the studies described in the previous chspter ~ere extended to
yield information abou t the distribution of tracer E12 on
the transcoba'lami.ns ,
Hall and Finkler (7) have produced evidence that yitamin
]312 absorbed from t'1.e small "towel is transported selectively
on ~Cll and that the biological half-life of the Tell - B12
complex is relatiYely short. This theo~J is supported by studies
by Zorn (33) in which he injected a TCll - 57Co 512 complex ~~d
noted that all the radioactivity had been transferred to Tel
by 24 hours. Chanarin et al (16) and ~ngland et al (20) on
the other hand belieYe that the vitamin ]312 absorbed from the
gut is bound hy the transcooalamins in proportions depending
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on their unsaturated 312 binding capacities at the time of
absorption, and that Tell does not have a specific function
in this trcJ.llsport.
3erQm s?~ples from the subjects described in the previous
section were fractionated on Sephadex G - 200 in order to study
the distribution of 57Co 312 on the tr~nscobal%~ns. TGe percentage
of the original activity bound by each fraction of the serum was
plotted against the time after admi nf.s tz-at.Lcn of the dose. T:.'1e
biological half-life of the TCl + 111 - 57 Co 312 and of the
TCll - 57Co 1312 cO'TIplexes could be obtained from the respective
activity/time cu~res. It was hoped that from an analysis of
the data by the occupancy principle an estimate of the distribution
of s t ab Le vitamin 312 could be obtained. T!1e occupanc.ies for
TCl + 111 bound B12 ~~d the TCll - 1312 fraction were obtained
by integ:r~:tting the respective ac-t.i.vi ty/time curves and, from
the ratio of the occupancies, the ratio of the c8~acities was
calculated (since the flow is constant.) If it is assQ~ed that
all the vitamin 312 present in the serum is bound to either TCl
+ 111 or TCll then, since the total serum 1312 is zno~m, the
absolute amounts of stable B12 on each protein C8n be
ascertaineo.•
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3ub:ject deti'iils.
As described in section 2.
:38.;:1:01 e u-""euaration
111e serum samples ~ere allo~ed to tia~ at room temperature
prior to fractionation. Visible insoluble material was observed
in some of the aamp'Les and these i,e:r.e fil teren. in order to
prevent the column membrane from becomlng clogged. Tnis
fil tration 'liP,S through a disc cut from cellulose acetate
electrophoresis p~per supported on a sintered glass base
(Uillipo:r.e Cor-por-a t Lon ) attached to '1 w;iter vacuum :;JUJnp. Th.e
s amp'l es from one suhject (case 11) had visihle Li.paemi.a and wcuLd
not filter through the cellulose acetate disc. In order to
remove the fat the samples were centrifuged at 2,000 x g for
twenty minutes and the serum was removed from below the surface
layer of fat.
3euhadex G - 200 chromatography
12g of 3ephadex G - 200 (?harmacia Fine Chemicals An) was
a1l07l8d to swell for three days in ::lpproxim?,tely 50C m'l , of
tris-TiCl buffer nT.{ 8.0 containing IT( NaCl being decanted once
in orde:r. to rem:::nT8 the 'fines'. ;';:ost of the bufferv:::w poured
off, leaving a thick slurry of 381 w~ich was deaerated with a
W8.ter vacuum pirnp ?t a }lressure of ?~p:proxi;n."te1;r 2.7 kFa.
The deg~,ssect slurry was uoured. into a chroTIn,tograp'1ic co Lumn
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a 1<26/70) to a gel colurrill ~ith a bed vol~~e
(7t) of approxamat eLy 300 mlomd a bed heig:'1t of about 5(0 rnm,
4 rn'L s erum s8.Eples were sep?Tated on the column by upwar-d
elution with degs.ssed tris-~-rcl buffer 8.t a flow rate of 12 ml/hour
naintained by ::t peristaltic pump (LKB 12000 Varioper1?ex pump).
In an attempt to prevent bacterial growth in the colu~ the
buffer W3..S sterilised by boiling Defore use, and O.O:!;
of sod.i.um qzicte was added to it. 39.mples were collected as
a continuous p::cocess, in om TTl t::co::cs.c fraction collector (LKB),
each sample representing 30 minutes' elution from the column.
The optical density was continuously monitored a-!; 280 nm using
a Uvicord 11 (LKB) linked to a chopper bar recordEr (LKB).
Although the radioactivity was recovered in the first 300 ml
of buffer collected (the bed volRme) a further 300 ml of buffer
were eluted before another sample was added to the column.
The s s rum sample,s from one pat.i errt were all run on the
same colQ~ whenever this was possible. The collli'11l1. was
calibrated with an in vitro lahelled sa"11ple of sermn from the
same patient before the in vivo saT'1ples were se-;nr<1.ted. The
samples from each subject, were fr"l.ctionated in order of increasing
radioactivi ty (s •e. t"le l8.te sam-r)les were seIJ8T?~tecl first) in an
attempt to minimise any effects of radioactive contamination
accumulating all. the column.
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Radioactivity measu-re'll8nt
'I'he 6 ml fractions eluted from t:1.e coLumn were count.ed
in the aut.omat Lc "'lrnrn.a scintill?tion spectrometer d.escribed
in section 2, for;:: convenient length of ti'!le ( U31t3.11v 20
. '_.'
minutes per sample) and a graph of the number of cOli..nts against
the fraction number was made. From this graph (for examples
see figures 3 - 7) the di'P between the two radioactivity 'Peaks
was identified and the two lowest values were allocated, one
to each paak , T'ne fractions were poe Led in threes, outwardly
from this point, until all the tubes containing radioactivity
had been incorporated. Occasionally it was impossible to
decide where the true minimum values lay. ~~'len this happened
the pe~~ values were compared with those on previous separations
from that subject (including the in vitro run) and the position
of the minima were obtained from a s?~ple whose peak corresponded
with that from the problem sample. T.'le results were calculated
from these pooled fractions (vollli'!le 18 mls) which were cOli..nted
for AC to 10C minutes depending on the activity present in the
samples. The samples from the first patients studied were cOli..'1.ted
for one period but later aamp'l.es were measured as multiples of
twenty minute counting times, in order to minimise any changes in
the backgrolli~d. Only 3tatistical variations in the background
were observed however, as described in the studies reported in
the previous section.
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Fi::;ure 7 3eTh~dex 0 - 200 ~el filtration of S~~Tles from case 19.
,~ s tanda.rd of either O.OT~, or 0.05( of the dose which
h~d been an~nist~red to the subject was cOlmted at the same
time and under the same conditions as the pooled fractions.
:~ accurate estimate of the background radiation was obtained
from fre~uent measurements during each batch of sa~ples and
this 'i'l8.S eubt'rac ted from the nurnber of count s obt8.ined f rora
the sa..rnp'l,e , '='he reBClining ao t i.vi ty , due to the aamp'Le , was
expressed as a percentage of the administered dose per Li,-':re.
of ae rum, Cn'l.y those va'Lues which were greater tha...'1. 0.01/;
of the origins.l dose/Ii t'T-'e of s erurn were included in the
results. After the sClffipIes from some subjects had been studied
the :protocol wa.s altered slightly to include the mea.,s1.lrement
of the radioactivity present in the ~ ml serum sam:pl e prior
to f~action3.tion. The inclusion of stey ~eant that the
percentage recovery from the colRmD could be estimated. Any
resul ts fro:n samples which indicated 2. recovery of over 120;>
were discarded in CClse this was due to contamination from the
col~'1.. Relatively few s8mples were discarded for this reason,
normally only the first one or two samples fractionated after
the in vitro separ8.tion. The recovery for the re'Jlaining samples
was in the range 80 - 120<.
Sxperiments on rates of recovery with samples labelled in
vitro (and t~us wit~ more radioactiyity pr.esent) have sho~m that
the normal recoveries from a collL~n are 90 - 10~,. It was obse~red
t~8,t in the v i.vo samples with a recovery of over 120c the
increased radio"'~ctivitywas predonin2.ntly associateil with the Tell
fraction, and not spreacc aquaTl.y betwesm the bind.ers.
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Results ~d Discussion
1. Tae distribution of' eluted -rpiUoactiye B12
Table 8 shows the percentage of the eluted'radioactivity
which was 'bound to TCll at a given time after 2.d.e-ninistration
obtained from individual subjects, for example, the percentage
of activity bound to TCll at 3 days post-injection varies
from 4;: (c?.se 17) to 40. (ce.se 1).
The data presented in ta~le 8 could be used to support
either of two contradictory theories, depending on which subjects
are selected. L~e results from cases 3 ~~d 18 could be used to
back up the view of Ha.ll and Finkler (7) and Hom (33) for
at 24 hours after injection the radioactivity bound to TCll
was only 2.5': and 8. e respectively. If on the other hand tae
resul ts from cases 1 and 10 are presented, there is good. suppor-t
for the theolJT that TCll might have a role in late transport.
This theory was originally proposed by Eenson et al (69 ) to
expla.in the observation of TCll bound 312 in subjects who had
been deprived of recent dietary 312 and in pat i errts who had
u..~dergone total gastrectomy.
It must be erTrphasised '1:t this]!oint, that wi t~1. the
excepiion of case 7 who is discussed l8.ter, s.erum sampLe s from
all of the 'Datients s tud.i ed in t'cli3 sect.Lcn bound in vitro
addad 51 Co 312 to bo th Tel -r- III and to r;;Cll. 'The binding p8.tterns
- 5t, -
C2...S9 ,- br.urnr er
Time after
injection 1 2 L!. 14 15 17
- hour- 79.3 '7 77.Q 72.0 62.6 34.2·~t T). I
1 '<lour 72.8 71.2 72.2 64.1 53.5 30.L!.
3 hour U,.7 4L.9 62.8 4g. 1 3~.8 21.3
5 hour 58.7 38.9 55.0 38.9 31.5 20.9
7 hour 3~. 1 24.8
8 hour 57.1 50.0
12 hour 26.1
1 day 46.8 21.0 36.7 18.7 15.1 9.2
2 day 10.7
3 day 40.4 1(..4 13.4 9.7 8.) 4.0
6 day 1o.E
1 week 42.4 111. ) 23.9 4.0 2.1
2 waek 2.1 0
3 vleek 0
J week 10.6 5.2
Table 38,) sClowin£" the percent"tge of eluted "tctivity
bound by TOIl.
C?....se JIll-Elba""!':
m" after.Lln'le
close 9 10 11 12 13
4 hour 98.5 92.5 96. 2 65.0 87.7
6 hour 91.5 89.1 93.5
8 hour 91.2 89.7 86.2 89.2
10 hour 90.2 -39.9
12 hour 84.8 67.2 79.3
24 hour 69.7 67.5 35.0 46.0
3 day 32.9 49.6 11.1 25.1
5 day 28.9
1 week 19.3 29.0 18.2 10.2 20.3
2 ':'leek 2<1..1 14.8
3 week 11.8
Table 8b) showing the percent?..ge of eluted
9-ctivity bound by Tell.

observe;:: for cases 3 an::' 13 were not due to the a'osence of
rcri.
3up:por t for the t'n.eory ths:t Tell has a. role in the tra..'1.sport
of 312 apar-t f rom that described as 'post-absorption' has
come from studies 'o;y T"'"ll (70). lie observed TCll bound
312 in the pl asma of a temim,l cancer :patient 51 days after
~'7
an oral dose of 1.12 pg/229)lCi of J!Co B12. At 4 hours
95 of tl'1e eluted ra.dioactivi ty was "bound to Tell, falling
to 22,:, at day 7. T:l8 fraction bound by Tell rem8.ined. more
or less constant until week 4 and then it increased slightly.
This Late phase of Tell transport was detected in only a few of
the subjects studied in this serie2 :possi'oly because the radio-
activity present in the serlli~ was very difficult to measure
accurately at this La.t.e stage. The s tudies by 3ngland et al
(20) also detected Tell "bOQ.'1.d E12 at relatively late times:
at 8 - 10 days after an oral dose 18, of t1:le recovered radio-
activi ty was "bound to TCIl in the s e rum from one subject and
3~0 in the serlli~ from the other.
~. 'E'1e hal f - 1 ife 0 f TCT + TIl "'1? rl c- m"TT..L .• - eJ _ 8.nu. OJ. 1 v ' 312
T~e percent3-;::a of the oris-iYlOl.l dose per litre of serum
hound by the relev~Ylt fraction of the serlli~ was ~lotted
8~ainst tine on log/linear grap'1. paper and a. doub'l,e or
triple exponential f~nction was fitted to the dat2. hy a
least squares iterative procedure as described in section 2.
Zx~~ples of the fitted functions are shovm in figures 8 and 9.
Results ~ere obtained from only eighteen of the nineteen subjects
because the serlli~ from case nlli~her 7 could not be completely
fractionated on Sephadex G - 200. A fresh serlli~ sample was
obtained from the subject and 57Co 312 was added in vitro
but it wae still impossible to seyarate the radio?~ctivity
into two components. Figure 10 shows the distrihution of radio-
activity iYl a fri1.ctionated s amp'l,e from ca.sa 7 compar-ed with the
type of se:paration nOr8ally observed.
The results from the fractionatecl serum samp'Les for the
eighteen patients are shown in table 9.
Oral administ~ation : The results for TCll bo~nd E12 from most
subjects were best fitted by a double exponential fUL~ction. Tne
first component of the funotion had a rapid turnover (t~
0.23 _ 0.67 clays) and this was followed by a sec01'1c1 :phase
(t ~ = 2.6 - 3 days in all exce~t one subject). In two of the
2.
suojects (cases 6 and 12) there was 8, fined section 'Hith a very
Long half-life (6.3 and 27.4 0?_YS :resyectively). A measure
of the '!:'Cl and 111 hound activity could re oot8.ined. only for
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_;. comparison of the G - 200 se}J.~_.-r:'~.tion of a serum
sample from case 7 and of one fro~ a noraal pool.
TC11 bound activity rc: & 111 b ound act jyity
Case Iength A (~0) half Ai half A2 half A3 haJ.f Le ngt h Ai haJ.f A2 halfNo of 0 life 0 life 1 life 2 life 3 of life 1 life 2
study (d) ( d) (d) ( d) study (d) (d)
-
1 7 5·4 00024 2.09 067
-
- - - 7 0.70 040 065 16.7
2 28 5·2 .025 1.27 .46 - - - - 28 •75 .24 1.1 5·9
3 51
- - - - - -
0006 8.2 58 1.27 2·4 1.43 13 .1
4 7 3·5 .038 1.45 ·71 - - - - 14 0.58 2.0 0·51 22·9
5 - - - - - - - - - 95 - - 0.86 7
6 29 - - 1.0 ·58 - - 0.04- 6.3 116 - - 0019 8.8
8 73
- -
4.0 .67 1·98 2·9 - - 73 - - 0.62 12·5
9 7 - - 105 .46 0.18 3.0 - - 14 - - 0.26 805
10 21
-
- 4·1 024- .6.0 2.6 - - 21 - -, 0.35 13.6
11 12 - - 3.5 .24 0093 2.8
12 21
- -
1.6 .40
- -
0.08 27.4 28
- -
0.68 19·5
13 7 - - 4.6 .23 0017 1·5
14 35 1003 .025 1.85 .46 - - - - 35 1.4' 0004 2.03 '7.3
15 28 8.4 .021 2.3 .42 - - - - 28 1.0 0096 2.7 708
16 7 - - 4.2 .30 0.19 1·9 - - 53 - - 0092 700
17 28 4.1 0.018 1.27 0·5 - - - - 28 3.0 0.05 3·4 5·2
18 39 - - 0.21 ·96 - - 0.04 17.7 39 - - 1.42 18
19 18 - -' 5·34 .42 - - 0.15 14.6 IB - - 0.97 17·1
Table 9: Bhowi.ng fractionated results of in vivo plasma clearance strud i.e s ,
5 of the 7 subjects, and in each c~se a sin~le exuonential
function "["'-3 fitted to the data points. The h2_lf-lives
ranged from 3.5 day s to 19.5 days and were slightly shorter
in the FA er~up (mean value 9.Q days) than in the controls
(mean value 16.5 days).
Intr~venous administration : Sleven of the eighteen subjects
came into this category. Tae Tell - 312 was initially cleared
very ra~idly f~ow the pla3m~ (t~ = 37 illinutes), a p~ase \~1ich
2"
was not observed in the oral group due to the slower rate or
entry of the tracer into the p'Lasma., In the oral patients
the maximum plasma activity was reached at 10 - 12 hours after
intAke and so the gradual accumulation of 57Co ]312 obscured
the phase of rapid clearance. This rapid phase was followed
by a second phase, corresponding to the clearance obse~red in
the oral group (t~~ = 0.3 - 0.96 days). In a few or the subjects
another exponential could be fitted to the data points to
give the final part of the f'unc t i.on , TIle TCI + III - J312
actiYity/time curve also showed an initial rapid phase similar
to that described for Tell - 312. This was followed by a
second section with a long half-life (t~~ = 5.2 to 22.9 days).
~nere did not appear to be any significant difference between
the results observed in the PA group and in the control group.
Table 10 gives the mea...'1 values for the half-lives of the
different groups wi. th the results expressed as + 3. E.II.
The first estinate of the half-life of Tell - 312 came
f'r-orn Hall and Finkler (7) in a s tudy io f the cLearance of an
- 59 -
rrC11 TC1
-
t (d) t (d) t (d) t (d) t (d) t 1 (d) t (d)0 1 2 3 0 2
All .025 .48 2.4 14.8 0.18 1.8 1l·9
Pat ient + .007 + ~ 0.6 ~ 8.4 ~ 0017 + 0·7 +
-
_ .2
-
- 5·5
All - .4 2·5 16.8 12.6
! .18 + + +Oral - 0.6
-14·9 " 4·5
All .025
·54 - 13.5 1"] .7
LV •. + .007 ! .2 : 4.8 ! 6.1
-
Oral
-
.28 2.3
- 16.5
Normal + .08 : 0.7 + 4.2
-
Ort:ll
- ·57 2·9 - 9 ·9
P .A. + .10 + 0.3 + 2.2
- - -
LV. .022
·51 - - 10.4
Normal ±.0038 ± .23 ± 5·6
I.V. .029 .61 - - 13 .1
, •A. ±.0079 .! .13 - - :. 7·0
-
Table 10: showing average h21f-J.ives for clearance of ]12 from the transcobo.1amins.
injected Tell - 57 Co :812 complex. The TCll - 1312 complex dis-
appeared completely after 6 - 24 hours and had a half-life
in the reGion of 1 hour. Further studies however snowed
that the initial c1e",.rance of Tell - 312 was even more rapid,
for half of an injeotec. dose of Tell - 312 left the plasma
in under 5 minutes (7;). In a similar study ITom (33)
injected Tell - 57Co B12 and found its half-life to be Ifl- hours,
and observed a half-life of 9.3 days for injected Tel - B12.
?cesults obtained by England et al (20) gave much higher values
the half-life of TCII - 312 was measured in three subjects and
found to be8 hours in one, 27 hours in another and. 28 hours
in the third. England et al attributed the short h8.1f-life
obse~led by previous wor~ers to the partial damage of the
TCII - 57Co 312 complex prior to reinjection. It must be pointed
out however that the previous studies with intravenous ad-
ministra.tion were maki.ng observations on the initial rapid phase.
3ngland et a1 gave the 57 Co 312 orally and therefore could not
expect to detect the phase of rapid turnover. Tne apparent
loss of all the 57 Co :812 from Tell by about 24 hours (7) Vias
:p o1:p.1:Jly due only to a f''tilure to detect the low levels of activity
present.
T0e results reported by Rom (33) for the half-life of the
TCI - 57Co 312 complex correspond very closely with the values
observed in the current studies. Although Hom described the
complex as Tel - ~12 it ~~la3 frs,ctionated on
- e.o -
Sep~adex rv'...7 - 200 2nd
is therefore directly co~p~.r~ole with the TCl + TClll binder
discussed here. ~ngland et al (20) on the other hand studied
the clear~nce of Tel - 312 and TClll - F12 separ~tely and
obtains values of 1.9 - 2.2 days ~nd 2.5 - 3 days respectively.
Although no direct comparison can be made it is evident that
study.
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3. Tae distribution oT endosenous 312 on the serQ~ binding proteins
The activi t2r/time CUT"TeS were p'Lo t t ed for the TCl + 111
bound 312 and for the TCll bound 312 and the respective functions
were inteGrated to obtqin the plasma occupancies fro~ the
data from each patient. Since the total flow of vit~~in 312
into the system is constant the ratio of the capacity to
occup~ncy of any ~art is eQual to the same ratio in any other
part:
F
e1
If it is assumed that the 312 present in serlli~ is all bound
either to TCl + 111 or to Tell then, since hath the total
capaci ty (serum B12 level) and the .i.ndtv.i.duaI occup~mcies for
both fractions are known, the absolute amount of 312 present on
either binder can be calculated:
x
Tne absolute amou~t of 312 bound to TCI + 111 was obtained
P...:H3. this value ~wv'as also ~x}Jressed as ~- 'Percent~t{{e of tb.e total
.seru..-n :312. TJne 'Y'.. e su'l t.s (+~hle 11) shov .J..:-'c> '~l';:l '"__-" '-..J \ vr... .J _ -o~J. 'I"; IJ cJ. .." .f'I \ .........
- (2 -
:rable 11 }.n esti:rrate of the amount of n2-tive
312 bo~~d to Tel + 111.
obtained, i:,ldic?~ting the variation between Lnd.ivi.dua'I subjects.
The percoenta,s-8 of t'1e en,ioG'enous 312 wni.ch was bound to Tell
var i ed fro:n 2.2'.. (e3.s8 3) to 52.1. (c3.se 8) ','lith a Bean value
of 1:3.2';':. A high serum 512 level W2,S noted in case 8 and it
is possible that an over'l.oad on 'l'Cl + 111 caused an overspill
on to TOll. It has been previously esti~ated that TCl has
the c2.pacity to bind only 700 - 800 ng 312/1itre of serum (27)
and this is consistent with the 8:'!.ount of 312 which is bound
in case 8 (815 ng/l).
The distribution of native vita.min 312 has been studied
by ~lall (27). He observ"ed that TCl had a potential capacity of
70C _ 800 ng P12/1i tre but that it 'was normally only 118.1f SEdurated,
i.e. carrying 350 - 400 ng/l. TCll on the other h~~cl has a
C2.pacity of 986 ng 512/1itre (28) but normally less than 2/ of
the available Tell is used at any given time during absorption.
T'8US about 200 ng 312/1itre of plasma is carriecl by ':':Cll and
350 - 400 ng/l by TCI + 111. Al ternatively t~1is e0111c1 be expressed
as 4.8 - 5.4, of the total 312 'bound to Tell.
- 63 -
In the studies desc:dbe(".. in section 2 it 1'18.S appreciated
t':lat an estimate of t-:le whole body stores of v i, t8J1lin 1312
could be made with data obtained by whole body monitoring
followed by analysis with the occupancy :principle. In view of the
very wide r8.nr;e of values estimated for tota.l body 312 hy vaTious
techniq_ues, it 'I'.a3 t':1onght to be of interest to pursue this
Doint.
It has already been sh07m that the ratio of capacity to
o ccupancy for any part of a system is equal to the f'Low of
Z'1other substance through the system. This flow into the system
is the same no matter 7~ich part of the system is being Uoea for
the measurements of capacity and occupancy.
C
nlasm8. C who 1 e body
F
e p'Lasma
e
whole body
can therefore be re-arranged to give
T:.1e equation
cap2.ci ty
who l e body occupancy 1 b ~who e cnv
o ccunancy p Lasna
x plasma :312
This expression C8n 'be used for estimating 'whole body 312 content
resardless of whether the tracer is given orally or intravenously.
The reduction of the whole body occupancy in the case of oral
administration is by the same factor as the reduction of plasna
64
o ccupancy "bec8.use l~oth are due to the unabsor-bed fraction.
Thus the ratio of the occupanc.i.e s is not 2.1 teredo
An estimate of t:le body stores of 312 was also obtained
from the unfractionated pLiSJ:'1.'1 C.8.t8.. If it is assumed that
the system has eQuilibrated then 2, measure of the total body
B12 can be obt2.ined. f rom the plasma content of 312.
- (5 -
I:"tteri8,ls "tncl methoGs
'11101e body measur-emerrts of r-adi.oact i ve vit::urin :B12
~ere made on four of the subjects described in section 2
cases 5, 6, 8, and 16. Details of their clinical states
"tnd of the doses of radioactive tracer 0hich they received are
plasma occupancies is described in section 2 as is the method
for measurin~ ser.lffi :B12 levels.
~ihole body mor~toring
At fren.uent intervals after the administration of the
57 Co B12 whoLe body B12 measurements we:re m8,de in a shielded
room whole body monitor. The radiation was !'lonitored by six
f II diameter x 4" thick sod.Ium iodide scintillation cletectors.
~~ese detectors were arranged in a circle round the patient's
body and attached to a vertical framework wh.lch was driven slowly
from one end of the subject to the othe:r. The amount of radio-
activi ty :present was summed throughout the scan which took
5 minutes. Ap:propriate corrections were made for background
radiation and for na.tu.ra'I body radioactivity.
The US8 of the whole body monitor allows a direct measure
of the body radioactivity to ~e made. It gives accurate :results
even at lengthy intervals after the adninistration of the isotope.
Initially the amount of radioactivity remaining in the body
can be derived f rom a me asure of the losses in excretion but
- u, -
w.i, thin a few d.8.Ys these losses "become so small tha,t accurate
measurements can "be made only "by serial whole body monitoring.
::tesults
1. f~om whole body monitorin~
appLi.ca't.Lon of the oocupancy principle to the data obtained by
whole "body monitoring are given in table 12. The s tudy continued
for over 300 days in all four cases. T':1.e measurements of the
whole body retention fall very closely (figure 11) on a single
exponential curve:
'\ (~)
.'"\. \ ...
The occupancy is taken as the integral of t':1.is function to
infinity : A /0::<.. rr.ne fact that A is not equal to 100; for
o 0
the intravenous cases is proba"bly due to rapid unphysiological
loss of ~bout 10: J of the injected tracer 312. Tnis has the
effect of reducing the whole body and plasma occupancies by a"bout
1~ but it does not affect their ratio.
2. from assumin.a; eQuilio'l"ation oT tracer 8.nd body sto~es
The results o"bt"'.ined in section 2 can also 'be used to estimate
the total "body content of B12. On the assumption that the tracer
312 has equilibrated with the endogenous 312 the data can be
used to calculate the t.ota.L body 312 on the isotone dilution
})rinci})le. If 0.1;. of the tn,cer is present in one litre of
_ (.7 -
Case f{a1f Plasma body
i;umber i, life e e 1312 312"'- <::<:.0 ~ J
( ;'~) -1 d rl d ng/1cl u. mf~·
5 89.7 .00109 67,7 825 .278 468 1.4/'
6 77.3 .00108 640 715 .138 149 0.77
8 69.0 .00130 535 533 .622 1700 1.5
16 94.5 .00112 619 844 .263 347 1.1
'1'3.01e 12 sho':line; estimated. ';Thole body 1312 content
from data obt~ined by whole body
monitoring.
."
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?ip:ure 11 functions
".+-. .."OOI.J8..lned.
~101e body monitorinp, of cases 5, 6, 8 ana 16.
SerUITl at i38y 50 and the 1312 level is 250 ng!li tre of s erum
then t':1.e total body stores C3.n 1;:.e estimated g.s
250 x 100
0.1
ng i.e 0.25 :n:o;.
~~e value of the tracer yresent at any given time was obtained
in t.ab l e 13. A mcre accuz-a'te e s t.Lnat e can be oot'3,ined from
flcat8. derived from the four >subjects 'i\"':1.0 were used for the whole
body mcrri tor studies.. The percentage of 57 Co 1312 retained
is ava.LLab'Le for these subjects and this can be used. in the
calculation instead of e.ssumi.ng 100'/ retention
results for these four are given in table 14.
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'Ytle amended
Case Nurnber
.D::L~Y·S af t er
tr·?,C'3Y 0'i'l:len 3 ~. 5 t 8 C; 11./
50 0.1'3.1 0.251 0.851 0.552 2.07 3 0.2 0.181
100 1"\ r.~~ 0.2;2 2.035 0.637 3.091 0.364 0.379v.ce..,.
130 0.587
140 0.569
150 O.ssC 0.313 2.305 0.784 3.469
200 1.0':L1 0.327 2.376 0. 0 03 3.778
240 0.343
250 1.329 2.~,63 1.014
300 1.431 2.(- 1.164
320 1.55
Case lTlhl10er
Days after
tr"lcer given 12 13 14 15 1t 17 18
'-1"\ 0.'273 0.146 0.193 0.125 0.655 0.183 0.151JV
80 0.33
100 1.104 0.19'3 0.191 1.197 0.233 0.2
135 0.177
150 4.379 0.269 0.287 1.388 0.291
160 0.282
180 10.583 0.332
200 0. Li35 1.509
250 1.693
260 1. 735
Table 13 showing: estim"ited va.Lues of whoI e OOG:r
stores ( . I'1:,::. ) assu-""inp; eouilibr9..tioCl of',In
tr"lcer ~312 and encioirenous 312.
5
6
8
16
};;Quilibr::o,tion
if 10G' retained
2.6
1.2
1.7
T~0Uilibration
( ~orrected_)
2.6
1.6
7/11.01e 'body
monitorin-R
1 L1...
0.77
1.5
1.1
T8-ble 14 showi.ng a co-nuar-Lson of the estiD'late:l
total cody 1312 ohh.ined by different
methods of analysis.
(values in mg)
DI3CU.33IO'J
~stimates of the whole oody stores of vita~in 312 have
been l8,rgely ba.sed on the mi cr-obLoLorr.i ca'I ase ay of tissues
obtained ~ost mortem from ~atients : three varying estim3~es
were obtained. T'.'lese were 2.689 miS., range 1.634 - 3.475 rng
3.48 - 10.95 mg. (7.1). A comb.i.ned isotope dilution and micro-
biological assay (75) gave values of 2.221 mg. (range 0.953 -
4.304 mg.).
Only two estimates of total :312 stores have been Bade from
dat8. from living subjects. The first was a study by Reizenstein
et al (58) in which an average value of 3.03 mg. was obtained by
kinetic anaLysds of va.Iues for whole body re'tention, faecal
excretion and pLasma cLearance after parente:':'8,1 administration
of radioactive vitamin B12. A second estimate of total body B12
was ca.LcnLa-ted for eighteen by giving a tracer dose of
radioactive cyanocobalamin and measuring the radioactivity and
microbiological activity in li'ler biopsies obtained at laparotomy.
This study by Adams et al (76) was based on the isotope dilution
principle and assumed that eQuilibriQ~ had occurred by the tine
of the liver bior,s~r ( 6 - 29 days l~"ter.) Values ranging from
0.96 mg. to 5.98.1 mg (mean 2.528 mg) were obtained.
The estimated values for whole body B12 content obtained by
whole body monito~ing with 2~alysis hy t~e OCCUP2~CY principle
are lower than most of the values obtained by the methods
described aoove. They ranGe fro~ 0. 77 mg. to 1.5 Mg, with
~ mean v~lue of 1.2 mg. Three of the four subjects monitored
were from t~le FA group (cases 5, 6 and 8) and therefore
were not strictly speaking in a steady state since their
input flow of vitamin 312 would be lower than their outflow.
The body stores of 312 will oe gradually depleted in these
subjects. It is of interest to nJte that although the lowest
estimate is f rom a PP. the two highest values were also obtained
from PA patients. ~he estim~ted stores in all four patients
were lower than the results obtained by assuming e~uilibration
from the data from the same four subjects.
The results shown in table 13 suggest that equilibration
cannot occur until at least 150 to 200 days have elapsed after
admi.n.is t'ra'tLon- The steady increase in the estimate obtained
fro~ the data from any given patient is due to the fact that
the amount of tracer in the serum initially is higher th~~
it would have been if eQuilibration had occurred.
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IN VITRC3'l'1]])IES eN TTS BINIJIN8-
B12 BY tTr:7l.:.j"'l...L., ~ ....~
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SC~CTIC2~ 1
can be determined by microbiological or radio 8SS'lY. The
distribution of this endogenous 312 on carrier proteins is
more difficult to evaluate. It C8.D be done hy sen"J.ration of
t~1.e S82"U;'11 on G - 200 followed by an aasay of the 312 content of
the fractions but this method is too laborious for routine
use and the small amount of B12 on TCll C).dds to the technic,:Ll
problems. The add i tion of a mass of r-ad.Loact i.ve 312 to serum,
f 1 1 d".t:' t· .... t .;] t·.t:' . 1 t OT 57 I"vO 31?o _owe ~y ~rac lona~lon 0 ll~en l~y ~ne amoun ~ -
bound hy each carrier protein gives information only on the
distribution of the added 312 and says nothing about the
distribution of endogenous 312. It W3.3 thong;'1t tint if smaller
amounts of J312 were added and if this adJecL 312 -""1ere selectively
bound to S:.J.y Tell then this could "be of :pr;:wtical importance in
detern.ining the amount of endogenous 1312 on the fractions and
would also give inforn.ation on the relative affinities of the
tra,nscoba18T"ins for added. 312. Accordingly "U1 inve,stig:;,tion of
the di.s t r.i 'en tion of 312 adiled to 38YUm in vitro 'HetS ini ti?~ted.
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20 ml blood s amp'l.es »ies:e o"btained "by venepuncture from
ten ho sp.i t a.L }J8tients, none of "hom were on vit8I11in 312
t:'1era:py. The blood waa collected into clean but not sterile
g18.ss tubes, allowed to clot and centrifuged to separ2,te the
~ach serum sa~ple was tha~ed at room temperature J)"!'ior to
the add.i t i on 'of radioactice v.i t ami.n 312. 'I'he r8.dioactivity was
measured in a thallilUTI activated sodium iodide crystal
(I~L type 663), 55 Thu dismeter ?~d 69 ~u deep, shielded
by 100 mm of le8,d. The crystal vr,as linked to a counter
ratemete"!' ",:",-'!",''''r'lV 310 ( J and P '~gineering ~ReadinG) Ltd). Tb.e
s ampl e was counted for one minute t':len applied. to a column
of Seph8dex G - 200.
Four radioactive vitamin 312 solutions were prep8,red from
a stanc,p.rd solution of 57 Co cyanco"balamin (specific a,ctivity
150 rCi/~z) obtained from the Radiochemical Centre, Amersham.
Addi tional vitamin B12 was f'urrii.sned from the diluted contents
of an 8..'I1'90ule of 1 mg/ml cyanco"ba13min BP obtained from Glaxo
Ltd., Greenford, 8ngland. ~'1e following amounts of radioactive
312 solution were addea to 4 m1- of serum to give the required.
concentration:-
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l. ?,.- ng/l 0.1 ml of 1 ng/O.2 rei / D1 solution-J
2. 50 II 0.2 ml II
3. 100 II 0.4 ml II
4. 62- 5" II 0.1 ml of 2.5 ng-jO.05 f ei / m1 aoLut.i.on
5. 125 !! 0.2 ml !!
r ?t:;f"I !! 0.4 m'L !!G.
-JV
7. 50::; II 0.2 TTll of 1n n[!;/8.2 lei/Tn.1 solution, ,I
8. 750 II 0.3 Tn.l 11
9. 1000 tI o LL :n1 II..
1(; 50CO !! 0.2 !n1 of 100 ng/0.25 f Ci / :rrl solutionIV.
TI,e nlli~ber of solutions ~re~ared was k8~t to a ~nimllin 0ince
the potential errors in dilution were thOU~lt to be greater
ths.'1. t'le errors due to t':1e variation in saP1:ple volume.
The s"G"""'le ,~e:ph:::.r!ex G - 200 COltL"1L11. was used for each s8:p2Ts.tion.
'7.."1e coLumn sLuarrt ws.s collected 8-3 nrevionsly clescribed
and t~e f r-act.i.oris 'were counted for 1 - 5 mi.nut.as (c.ep8Dcin; on
the activity present) in 3. Fackard well-type gamma sc.trrt i.Lla.t.i.on
spectroneter. A standard of kno~ll radioactive 312 content was
counted in both the 2.Uto 5cuTr:118. counter and the count.er ratemeter.
A correction factor was obtained -illich allowed a direct comparison
of the results obtained from the two instrw:nents. The recove~r
of radioactive B12 fro:n the colw~ could be calculated although
the add9d and eluted 3&~yles ~ere counted in different instruments.
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Resn.l-t3 .en:,,). Jji.sCllssion
The results S'"O'i7Tl in t2.bles 15 and 16 demonstr8.te tl1.at
t'cle D'lSS of a/Wed. vitamin B12 does not 2.1ter the pattern of
its distribution bet'Neen the car-ri er proteins. 'rele yercent8.ge
of eluted. ao t i vi ty bound to TCll in t~'le samp'Les fro:n pool 1
obtained from repeated fra.ctionation of ali~uots of a serQS
pool to which a constant a~olliit of vitamin E12 was added, the
mean and the s tanua.rd deviation being resy8ctiveLy 81.2, and
2.1>. The mean and standard de1ri8..tion were calculated for
the ('tat? shown in table 16 2Dd. the results ":fere :
pool 2 72.7/ 2.1, pool 3 68.0, 2.8, pool 4
c'
; ~ ; 73. c>;
-
+ 6.1, , Dool 5 60.2, 3. T and nool 6 74.7::: + 4.3,.
The unsatur2~ed B12 binting c8.Y8..cities of three of
the serum pools could be estimated from the recoveries obtained
when a large mass of vitamin B12 was 2.dded. In the case of
pool 1 only 28.6, of the added r?.ilio2,ctivity was eluted with
the transooba12rr~ns when 5000 ng 312 was added/litre of serum.
This is equivalent to 8. UBjC of 1430 ng/l. Recoveries of
34.7 and 16.4, were obtained when 5000 ng/l and 10,000 ng/l
were ~dded to pool 5. The UBBC for pool 5 is therefore 1688 ng!l.
"
"f:1.en 5000 ng of :B12/1itre Vias 2.dded to pool 6 a recovery of
32.3.' was observed which corres1Jonds to a U3BC of 1615 ng/l.
'Y1.8 rema.ining vitcunin 112 wa.s not eluted as a neak of
r-ad i.oac t i vity (as described by Sam and ;..'":1.1uwalia (28)). Instead
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Table 15
\
J'l.oi".ring the effect of the mass of vi f;q::nin 1312
added to sa~ples of paolI on its distribution
hetween the transcooalamins.
Similar results were obtained in experiments with
5 other se~lm pools (see table 16).
:?ool Number
Eass of B12 Added 2 3 4 5 6
n2"/litre
25 70.4 55.
6 71.7
50 74.0
84 £8.2
168 70.4 6C2
250 71.5 1:5.1 58.7
72.9
500 70.4 75.3
1080 7.1.8 66.1
2000 61.3 78.2
3000 T9.9
5000 0.6 79. 6
10,000 62.7
Table 16 showing the percent8.;e of a~aed 312 bOlli~d
to TOIl ann its yp.riation with the naas of
312 add.ed.
S00e of the Il02t t activit;T eluted Gradu~lly froA the colQ!h~
and tQe reE'tainder hecame 3,ssocic:;,teo with t':1e foel. This 3;plJ8.r,~nt
binding of free 312 to 3e~hadex G - 200 is discussed in t':1e
next section.
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CB,:3~R.'TATIC1'-I,)
'Ene literature on the use of 3ephadex G - 200 to se-oarate
fre'" and. transccos.18min oound radio'1cti'Te vitai'1in 1312
sugCests that when an excess of 57 Co B12 is present it is
eluted as a clearly defined peak which becrulse of its smaller
moLecuLax size comes 19,ter than the protein o011..l1d. 312 (,28).
All the radioactivity ~nich is introduced into the cclu..~in
the form of 57 Co B12 elutes either in the tr~l1scooalamin
bound or free vitamin B12 peaks.
Fractical experience however has not supported this view.
In· the first place the free vit8~~n ]12 peak frequently was
not cbserved , :3econdly rates of recover;'{ of 200 - 300:: were
occasionally obse~Ted when 8n in vivo labelled sample was
fractionated on a colurnn in which the precedini'C sample had
b 1 ..... 11 '1 "+11. 57 0 1:\12 dn n' 0+ d' . , t 1"' ;:l r e r"'0-"_peen aue _8". Wl,. . O.u an e In v.i Jro an wrn.cn -,-_... _
conta.i.ned su1"stanti8.11y more rar'1.ioactivi t;y. The excess or
add.i,tional .rad.i.oac t i, vity was eluted with Tell to a much greater
extent tnanwith TOl but it was not confined to Tell.
These oose~Tations suggested that there was retention of
free vi t8.min B12 on the 3eph8,dex columns and poss i,ol;,{ also thcd
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there W2.S tinrLing: of Tell - 312 to the .3ep':ls.dex. This latter
p':leno;nenon han be en obs er-ved by :Iom (12) and 8.ttributed to
the use of low ionic strengt':l buffers. This expl~xation does
not account for t':le binding observed in the present studies
nor does it account for the retention of unbound 312 on the
colurrill. Further investigations into the problem were t':lerefore
carried out.
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:":ate-ria1 s. rn.et'lOd8 "lnd -results
1. :Der!onst-ration of t':1e -retention of :812 on columns.
~~e retention of vitamin 312 on 3ephadex colw~ns
was deIonstrated initially by t':1e recovery rates observed. It
was cons.i.at.errtLv 811 m 'In that if em in vitro labelled ser-um sample
w~ich ~~s used next for an in vivo laoelled sqmple containing
approxiTTl2.tely 0.001 yei of
r;7
-' Co 312, t1"';.en reco·veries of
200 - 30C( could be o bba.i.ned f'rcm the in vivo aamp'Le , This
effect could not be shown when t";'Jo sanples of approximately
equal radioactivity were used because the resulting increase
in recovery would be only a'oout 5.
1".'1e fact that vi t.ami.n 312 W"l.S being retained on coIumns could
also be shown oy the identification of rqdioactivity in the gel.
It Vias possible to locate this r8.c1ioactivity by measuring t 1"le
co Lurm in t':1e whole body morri.to r and also by dividing the gel
into aliquots and counting in the auto gamma courrter ,
A co Lumn which hare re2cherc the end of its useful life and
was being di.s caa-ded W?.8 di,v.i.ded into 8,p:oroximately 8 ml
of' ,+."zrac t i.on s , As far as was possible the fractions were obts-ined
without mixin:~' "because it was ~1.oped that it wou.Ld "be possible
to locate the position of the r-ad i o act i "8 B12. The co Lunn
fractions were count ed for tyro minutes each in 2. Packar-d 8.uto-
g8.msa scintillation s~ectr8meter. The Y.'8.dioactivity was
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predominl.ntly "i.ssoci?ted. VT:. t":l t~1e bottom 30 - 35 r"l of sel
and wi t~.1 t":le nylon support nemb:c?ne 2.t t'1e bo'tton of t~1e
column. 30rn.e :r:otdioact.i-.rity was f'ound th:r:oughout t":le co Lumn
and the:re wa.s '3. subst8.ntis.l arnourrt ae so ca a't ed with t":le top
illeillbr~ne. r:L'ne total :radioactivi ty p:res",nt "gas e,:~uivalent
.I- n 0;1r.: ("\'
,,0 J.'_cu r: TDis t:reatment was repel.ted for a second
r'7
co Lumn and 0.049 rCi J I Co 312 was found distri'outed in 2-
si:rLil;:tr way.
It had been ohserved. tho:,t after the co Lumns had been in
use for 2 - 3 ''leeks "bacteria.l growth 8-pyeared on the 10','ier
n;ylon membrane. This g:rowth was in spite of the use of
i,,;r
O 1'"12'" (:'1 \ of' rl' . ';" b t cl ~ h ~T T.'~' r: V) 0", sooaum azi.oe In every a en 01 .u1_er. .in an
attempt to see if it 'Has the p:resence of the bacteria which was
responsible for the retention of 57 Co B12 on the gel an
entirely fresh colu~"1 was prepared. A s~~:ple of radioactive
vitlmin B12 solution (10 ng 312/0.025 ~Ci) was added to the
coLumn with buffer and blue dext:r?..ll solution. Cnly 25:'<
of t'le 8,deced rM.dio"'_etivity was recovered in the fractions
corresponding to the elution volume of vitamin 312. T~e
residual raJlio::wti-vity in the co Lum..."1 was maasirred by counting
in the w~'1.o1e "body monitor. RacUo8.ctivity corres};londing to
0.003 fCi (.±. 10;') was detected although 0.019yCi (755': of
0.025 rei) was expected. ~':=ost of the radio8.ctivi ty must h ave
eluted grac.uall:-r wi th the buffer ....vhLch was run through the
cclQ~~ hetween s8nples.
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2. I~ stud:.! of ::1e.thods of ""'-amo~rins 1312 r,.-.OT"l 3ep~2..dex.
'I'hi s s tudy arose from. the obseryqtion th~,t seru..l"'l could.
pick up 312 in transit throue;"h a co Lurnn , ,n thouf;h ;Tl03t of
the rad.ioactivity had been removed from the collli~~ described
above, it was decided to apply a sample of ser~u to ~'lich no
radioacti~iity '1.8,(1 been actded. in order to see if it could
pick up 57 Co :512 froI7l the coLuran, Normal human serum did not
bind any of the remcdning racUo·activity present. The experiment
was repeated with a prepqration of hog intrinsic factor because
it has a greater affinity for vitamin 312 than that of human
se rum, A v exr; smal.I amoun t of ra.dioactivity "T8.S botmd
s e rurn obtained from the IT'GTlunolo,::;:;r TIepart:'11ent, \"'estern Infirm?ry,
(O.OCC.11Ci) by the hog intrinsic factor. A sam.pIe of chi.ck
Glasgow was finally added to the colu...8n. Cnly slightly more
radioactivity (0.0005 tCi) was bound by t"le chick serum although
it conte,ins a. very avid. vitamin 312 binder.
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:Discussion
The binding of 57 Co 312 .to .3ephadex is an i'1lDortant
practical point which if disregarded can Rive rise to mis-
leading results. 'Iavill9; said t::nt it is 2.pparent t':Ht only
a small ~30unt of this 312 can be removed from the 3ep:ladex
by serlli~ in transit. ~~is is therefore a problem only when
the aerum contains very little r-ad.i oact.Lve 1312. TInre appears
to be some 57 Co 1312 whi ch is held on to the gel very fir:nly
and it is not removecl even by an avid binder like chick aerurn
binding protein.
There is no evidence that the gel is able to remove 57 Co 312
which is bound to the transcobalanins for the results octa.ined
from a Ser1.L'11 pool are consistent regardless of 'lihether the sample
is fractionated early or late in the life of a colQIT~.
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Ilifferent for:ns of vitaT'lin :B12 have been re:;Jorted in the
domi.narrt form (to - SO/) but adenosylc;:Jooo_13TIin and
hydroxocobalamin a.r'e also present and oyano ooba'Larrd.n is
occasionally observei (57). ~s there h8~e been no reports
of the distribution of these forms on the transcob2~amins,
the present studies ~ere undertaken to examine the possibility
that some specificity of binding takes place.
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It is ~nown that sone of the forms of vitamin 312 are
light sensitive (57) and in conseQuence all the procedures
clescribed in this section war-e carried. out in t~'1.e dar~<.
A fres':1. coIumn of 3epha.d.ex G - 20C was set up ins.
a ark roon illuminated "by two :LIford '59.felights', and the
COllL~ was calibrated with a 4 ml. s?~ple of serum to vh1ich
57 Co cyanocobalarr~n had been added. Tne elution volu~es of
the t~o tr~nscobala~inswere noted. Buffer was run through
the coLum...'1 for several days in or~ler to remove as much of the
cyanocobalamin as possible.
"Blood 3:3.:
T
rp1 88 were obtained from four subjects by vene-puncture
wit':1. a foil-covered syringe. The blood was transferred to gl2-sS
tubes also wrapped ~ith foil and centrifuged after clotting.
The serum was re!'1oved in the dark room and alia_Hots were stored
at _20°C in foiled plastic tubes.
4 ml s8.:r,ples of serUJT1 were applied in darlmess to the
colurrill and the eluant W9,S collected in 30 minute fr'Owtions as
described before. These fractions were pooled to give a TCl +
111 sample and a TCll sample, and the samples were stored in
foil wrapJed containers at _20
0C.
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T centif:'..c8,tiC?Yl of the fo~::rrs of vi t'?3,in :2.12
7:1i8 P?-rt of the work was caz-r i ed out by Faro_uhp.Tson
and full details of t~e clet'-1od ar-e given else',vhere (77). Briefly,
the eluant was di~ly3ed ove:r.nipht to remove t~e salt which was
present at high concentration in t'-1e huffer. T:1e vitamin B12
was extracted by refluxing for 30 minutes with eth'?~ol. ~:1e
co?~ulated protei~ pToduced WA-S removed. by filtration and the
coha12min was extracted with p~enol/c~loroform (1 : lV/v).
The organic phA-S8 was t'-1en s~2~en with diet~yl ether/distilled
water/acetone (4 : 2 : 1 v/v) to extract the cobalamin into
the aqueous phase. This aqueous phase was rotary evaporated
to a small volume.
The cobalamins present in this extract were separated by
thin-layer chroTIl?Ltogr'?"yl1;r. The concentraticm present are
so low however that visualisation of the separated forms is by
bill autogr?Lphy using a vitamin 312 d.ependent ~. coli mutant and
a tetrazolium ~rowth indicator in an agar overlay. ~~e growth
zones of the organism give a measure of the forms of vita~in 1312
present.
7he extraction and bio autographic procedures were carried
out for three samples from each of four suhjects. In each case a
aamp'Le of nnfrac t.i.ona.ted serum was studied in aidi tion to the
fractions corresponding to Tel + III - 1312 and to Tell - B12.
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Results and discussion
for~s of vitamin 312 observed in
tne Tel + 111 and Tell extracts.
serun are present in both
In sll subjects methylcobalartin
8!1r1 'j,denosylcob"'.lamin were cbserved , ,:Iyaroxocoba,l2.l"in and
cyanocoo2,la;;lin »es:« found in s.?nples from two and three of
Ule cases respectively. Full det8,i13 a,re given in table 17.
There is no evidence in this study to support the view
that one form of vitsBin 312 is specifically carried on one
The observation of cy"'~ocobalamin in samples
from three of the patients was i~tially thouGht to be due to
r::;7
the c2,libr"'otion .run on the co Lumn (w~'lich used J, CO cy,mocobalamin).
Cya,nocobalarnin was also observed however in the samp'l es of
nnfrac't.iona'ted serum which were s tud.i ed and it must therefore
oe consi~_ered to be genuinely present.
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Form of 1 2 3 4
Cobal arrri.n
Pre sent T C1 & 111 TC11 TC1 & 111 TC11 TC1 & 111 TC11 TC1 & 111 rI'C11
Methyl + + + + + + + +
Cyano + + - + - - - +
Adonosyl + + + + + + + +
Hyc1roxo +
- - - - +
'I'ab'Le 17: showi.ng tho f or-ms of B1 2 present on t he t r nnacoba'l anu.ns ,
Little is known ".bout the '0:8Y in 7Thich vit,,:min 312
IS
other th"',n the fact that when one is absent the 1312 ~bou:nd.
8.d.ded to aerum in vit.ro is distributed on the tr"ll13cobalamins
by tho se whi ch are pr{3Sent. For this reqson a stur'Jy of
the p8.tterns of the binding of added 57 Co 1312 Vias initiated.
Senurr samples were obt'1ined from control subjects and a.Lso
f r-om V'l.tients suffering f rcm a vaxi.e ty of diseases.
In addition to the study of the distribution of aclded
312 the amount of :512 bound was also considec::'ed.
of the unsaturated 312 binding c "'}J3.city (1J33C) obtained froD
two different ::'1ethods was rnade ,
Mc.:de-yoia1 s ~mCl. HethoCls
3e~~~ samples were obtained from 100 subjects. In order
to facilitate analysis and presentation of the results they
have been grouped accordingly to the clinical sta.te of the
denor. T'::le ni.ne groups and the relev8-.'1t clinical cleta,ils of
each subject are given here.
Groun 1 PeY'nicious anaemia
Cases 1 _ 16 in this group of nineteen all presented with
megalo'o18.stic erythropoiesis and all h ad '1 pent;:lg":tstrin
f'lst achlor~ydria. T~ree of t~e patients ~ere not anaemic
on pr<3sent2.tion : C::13e 3 :;::,resented with Suh-clCute cO""lbined
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de0en-2r:·~tion, C8<3,2 5 71i t~l per.i phe ra.L nell.ritis and C2.Se 13,
durinc in'restif,·C'_tions :':or ill healt'1., w'as observed to have
mac'ro cy'to s.i s , ".11 lJ'1tient.s h ad low s erum vita1'lin 312 levels
of liver in the titree 1'1'1·Y8 prior to "',dmission to ho sp.i, t'1.L
·C +..
-raema t i.ru,c
t:ler8.py ':;'13 '!;i t'leld an5 over the next f'ew d8.ys a reticulocytosis
T13 observed and one 'seek after admi se.ion the er-lt'clropciesis
was found to oe normoblastic.
Included in t~is group of patients are two (cases 17 2~d
18) who had }Jreviousl~r undergone total gqstrectoI'lY and who ,
like cases 1 - 16 were unabl e to a'osorb radioaotiye vit.ami.n
B12 unless it were given with a source of intrinsic factor.
Cne of these 9atients (cRse 17) had received paxenteral vitacln
B12 since the oper3;tion and the other (case 18) since the
development of q megalo'olastic anqemia five years after the
operation. Case 19 had a defect of intrinsic factor med.iated
aos'Jrption of vit ami.n 312 which differed in Lmpoz-t arrt respects
fro~ th~t 7nlich is fOQ~d in pernicious 2~aemia hut ~hich
permits her entry into thi0 group. She presented at the
8.,cse of 26 wi, tn a rneg-alob18.stic anaemia and a low serum 1312
level. Treatment with parenteral vitamin 312, folic acicl and
vitamin C induced a hae"!latological response but ,t~en treatment
was withdrawn it \V"'_S noted that herserlLrn -312 level fell to
'borderline values. Al though acid and intrinsic f':'octor were
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:9reS2::1t in her 3''13tric juice, "-bsoY.':9ti:m t.e s t.s ,;,:'i th r'lclio-
active vi t::u'lin 512 shov;ecI sub--no rma.L abso rp t Lon ~vhen t':-1e
oose was given alone but norcal 'ltsorption when the dose
1 ""tent vi taT'lin 1312 ('!eficiency
).11 t-Nelve :patients in tilis ~;roup h ad normal haemoglobin
levels but evidence of Lat.errt vit&llin 312 deficiency in the
form of a 10VI or 'oorderline SerLL'1J. vitamin I312 level and rna.L-
absoxp t i on of vi tami.n 1312. The condition was -reg."l,rded as .
l'ltent.oeC~lse cytological evidence of vit'lmin 312 deficiency
was either absent or not sought. In ten of the :patients
h'lematinic thera:py had not been given before the samples were
obt~ineQt the twa exceptions being cases 30 and 31 in w~om
:parenteral vi ta:nin 312 t'.1er'lIJY had "been ini tia,ted. Tb.e pa'tLen.t s
c?~,e under observation for a variety of reasons. Those with
diabetes mellitus had been found to malabsorb vit?min I312 in
the COU:!:'3e of ano tner study and their Lmpa.i.red capac.i ty for
a'osorption had 1::een shown to be unrelated to h~r:Po.;;lycaemic
drug therapy. The two p(;:dients w'i th rna.Labeo rp t i.on (c8.ses 24
~~d 25) h8.d co~e under observation because of weight loss and
both had other evidence of ma.Labsorpt.t.on and had partial
villeus atrophy on a small bowel bi.o p sy , The p?tientwith
-~ t '.l-' ( 2'-) t d -t' t'· f" 1- 'l.8""'S rl t i s \ case.C presen e 'JVl n par-ae s nesaae 0 'tiLe arnns ,
The :patients who h.ad previously undergone pa'rt i a'I .;:astrectomy
came unrt er oOFiervation fa:!:' a va:!:'iety of re",.sons and t:'1eir
s erum 312 l,,"vel '!','?J3 esti"l-"!,ted as part of t'le Gener;:Ll exam-
. .i na't i.cn , Case 31 yre,c:;ented originall:!' w.i tn t~lyrotoxicosis
and clTcin; routine immunoloc~ic2.1 survey was fOU:."1.d to have
D3.riet2.1 cell antioodies. This olJ3ervation leO. to
-l- "avroyD.l.C
g3.stric mucosa .
Grou'!) 3
to ahsorb vitamin 312.
The nine patients in tnis sroup all h~d q norm~l
capac.i ty to aC3o:?.:-1; vi t.ami.n 312 , 'ou t ",,11, at some time,
had 8. low or "bord,erline serum v.i.tc.unin 312 level on more th?~"1
one occg,sion. The s e.rum vi t.ami.n 312 levels were estimated
in cases 32 and 33 bacause the clinical history sue;t;ested.
malnutrition; in case 34 aecause the presenting s~~ptom
raised t:le possibility of vi tal:lin :312 deficiency and in case
35 because a macrocyto:"is was noted on routine peripheral
blood film. Ca.se s 36 ::111,1 37 bo th had anae;nia without dis-
tin:=;uishing features out aocomparri ed oy a ver;.r high ~. -S. R.
and in bo th patients S8":'UTIl 312 levels of 80 - 140 ng/l were
oC3erved. over a pe:doil of several months , In c a.se 33 the
s erum vi t"'.min 312 level ,,;as ccet8rmined OeC:1U3e of t'l.e l1.istory
of g~strectomy and in cases 39 ~nd to the seru'11 vita~n 312
level had teen ob3erved to remain oelo~ 100 n~/l six months
after parturition.
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of t~1is P,Tou:J cut 03C;:;'US8 t':ley nresenl~8rl vii tll. a :nega.lobla.stic
3naemia t~ey h3~Te been includ.~d in other groups.
GrOU"D 4- ~'e;:aloblg.3tic anaemia due to folate
deficiency
meg'3.10blastic erythropoiesis and low serum folate levels and
.?..ll \7ere subsequently found to h ave a no.rma.I capac.i t:r to
absorb radioactive vitamin B12. Cne patient (case 43)
was not ~~aemic on presentation and the haematological
investigations were -precipitated by the -presence of a high
mean corpuscular red cell volume. In case 41, who t~ree years
later was re-3.rl...J1li tted to ho s'pi. te'_l with a recurrence of
me,s'':1101,lastic R.ll8,emia, the aetiologic3.1 f?octors were cO:lsicerea.
to be malnutrition and. a1coholism. Iolycythaemi"1 s aconda'ry
to ,~:ross pulmonary disease was consi dered to be an
aetiological f"1ctor in case 43 and myelofibrosis in case
t~5. It couLd not be clearly establi sn ad in t':1e reJ1?vining
cases wh;:;,t the Cffilse of the deficiency was. L~e -possible
aetiolo~ical significance of a carcinoma of the rectQu ~hich
h~d be~n excised five years previously in case 46 was also
not clear. As already noted case 4t also comes into the
catego~J of a patient with a borderline or low serQu vita~n
312 level 'out a no rma.I capacity to absorb 312.
o~
" I
7he seven p~tients in this gToup ~ll presented
vii th a me€aloblastic anasmi.a cut in no case has the aetiology
OJ: the anaemi.a be'om defined wi t:l. 2"cceptable precision. Case
to folic acid deficiency, but refused consent for various
investL~8tions. 311e was discharged from hos-pital on
oral folic acid and did notre-attend until 18 months later
by whi ch time she was grossly myxoedemat.cus , Al though
not anaemic at that time her serQrrt vita:nin ~12 level was
f'ound to be low and her oapac i, ty to absorb v.i tamin :312 was
also low. Case,1.Q was a blind, ill-nourishect, varmi.ncus
woman wi tn obvious 10c201 secon(1.ary carcinoIi!a of the vul ve:
Cn adru ss.ion tllere was evidence to suggest vitamin 312 deficiency
but she had. a normal capacity to absorb vitamin :31'2. Treatment
~ith yitamin 312, fola,te and vitamin C produced some cenefit
but she ~a8 still anae~ic when she died four months later.
Case 50 had gross rhelli"12.toid arthritis, refused investigations,
and h2.8 attended hospital on only one occasion in the two
years since she had in-patient treatment. Case 52 nad 8-YJ.
anaemia whi.ch was considered to 'be megaloblastic "out which
responded incompletely to vita~in 312, folic acid ani vit&~~n C.
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Ca,se 53 had :.oresented w.i tn a negaloblastic anaemia and,
clinical feat~,lres sug;-estive of ;:3,rfans 3yndro:ne. 1"'18 dia,gnosis
of cystathionine s~~theta3e deficiency ~as establis~ed but
the aetiolo,T,Y of neE;"aloblastic anae::lia 7JaS never s","tisfactorily
defir18.i. Case 51 was noted to have a mild anaemia while
convalescent froill a myocardial infarction and the evidence
sugcested folate deficiency. After one month of trea~ment
with folic acid ho~ever, the serwu 312 level remained at a
borderline value in s:.oite of the no~al capacity to absorb
vitamin 1312 and tb,e patient C2.J1 therefore also be c' aas.i f.i ed
in group 4. A similar situation occured in case 49 who
was found to have a megaloblastic anaemi.a after a haematemesis.
Although the :patient wastreatecl with folic acid for a lengthy
period of time, the serThu vitamin B12 level remained persistently
in the region of 80 ng/l in spite of ~ no~al capacity to
absorb vit~~in B12.
Jaundice and liver disease
This grou:.o of'eleven patients was stUdied because of the
kno~TI relationshiu between liver f~~ction and vita~in B12.
Cases 55 - 60 ha~ presented with obstructivej~~ndice and
tne final di8<~osis was established at laparotomy or post-
mortem. Cases 61 - (; 5 had parenchymal liver disease 8n8~the
di8.gnosis was ests,blised 'oy conventional techniques including
liver biopsy in every "p8,t L mt . ,)221p188 were taken at different
ti""n.83 in three p-;,t':ent,s \yi tIl no tre~t2ent in the inter"":T8nin;-
~eriod, in case (5. 3teroic th2rapy 112...:1 "been Lnat i. t.uted aIle.
been giV 81'1 in C:'3,.:"3t; 61.
The control subjects
in good. h2alth.
fem::1,le.
The :Tl8,jority of subjects were yOLL"l"; and
:3eru_0. sarn})les from s i.x ca:3eS of tob:wco 8.lil"bl~Topia and two
cases of Le"bel's disease were made available oy Professor
·,'T. S.Foulcts, Tennent Institute of OptlHlmology, \'festern
TDe diagnostic criteria were determined
"by the responsible clinician.
Groun '3 lA-tients wi t.h miscel1 ansous di.seases
JJetails of thedi8gTIosis made for each of tDe twelv-8 patients
included in this group are given in table 26.
- 3d -
10 - 20 ml samp Le s ofblo0.d. were 0 bta.Lned by venenunc tur-e
and the blood WqS collected into clean but not sterile glass
tubes. Tne s~nyle3 ~ere allowed to clot at rOOill temperature
and '[;-ere centrifuged. wi thin 3 hours of collection to s8}J8.rate
oThe s erum was stored at -20 C and 2~S faT as is
known ti1e samples ','Jere tl:1"'~';red only prior to the studies reported.
in t~is section.
'S.?dicactive vit;:)JI1.in 1312 solutions
To each 4 ml sample of thawed serum &~ a1i~uot (0.1 ml)
of standard radioactive solution was added. ~~is solution
>;7
corrt a.i.ned 100 ng of 1312 per m1 and also 0.2 5,Ci of /, Co 312
per m1 ~~d will be expressed as 100 ng/0.25rCi/~1. Earlier
work was carried out using a 20 ng B12/ml solution of cy&~ocobalcmin
wt th betv;e2n 0.1 and 0.5t8i/m1. 0.2 ml of this solution
was added to each 4 ml serTh'll sample. These standard solutions
were prepared from 57 Co 1312 specific activity 210 jlCi~g
obtained from Fhilips - Duphar 137 201l~~d and from 57 Co 1312
specific activity 150 j\Ci/ys obtained from The Radiochemical
Centre, ..1"'llersham. The aclditional cyano coba'l amin in t':le s tanda'rd
solutions was added by the dilution of the contents of an
ampoale of 1 mg/ml cyanocobalamin BF obtained froB Glaxo Ltd.,·
Greenford, ~ng12nd.
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;erUI:l vi t ami,n 1')12 levels
------
rrl1ese wer e (l,..etermined b:r Lactobao.iL'l.us Le i cb..manrri a.ss ay
perfo:r3ed hy t'Cl8 s t af'f of tllS Deca.rtmen't of 2~aej1')atolo~r,
30uthe:rn Gene:ral --iospits,l, Glassow.
T:'l8 unsatur'tted vitamin B12 bindin;>; capaci,ty (U33C)
of the serum saJ11ules was measured by the method of Gottlieb
et 8.1 (78) -w7i t~1 minor modifica.tions. ;L~ excess of 57 Co B12
The samp'l e 712S
0.1 m1 of 10 ns/0.025 t ei / m1
57 Co 312 was added to 0.2 ml of serQm.
Vias added to the samples
left for a few minutes whereupon the unbound vitamin 312 was
removed from t:'le serum by absorption on to 2~-' (i"-/V)
albuenin-coated char-coa'l , A 30; solution of bovine albumin
from Armol:.r J? harmaceo.td cal. Co. Lt.d , , E'tstbourne, -~n;~)and
w a 3 u.ved wi th ~~orit I AI cha'rcoa'I from t:l8 Amend :Drug and
Chemical Company Inc., ~8W York. A fresh charcoal suspension
was 1Jrep?,red for every batch of U5i3C detem.inati:ms. 0.5 ml
of charcoal suspension was added to the serlli~ and the mixture
was shaken at .rcom temneratnre for 5 minutes and then counted
for r-ad.i.oac t i vity for 1 minute (in a 30di1.1;!l iodide crystaL
linked to a counter ratemeter I':'; 310). The char-cca'l was
renoved "by centrifugation at 1000 g for 15 minutes. The super-
natant, containin,';' the'sernen 'bound 312, 'iT2,3 count ed for
,-:""'".-,D'~·"", x ?lidec.. ~2r :nl
of ,3erU3
~ractionation oT se~lli~ samules
G 200 as descrioed in Ch3uter 1, section 3. ;In exce3S
of vi tSf'lin B12 (2500 n~/litre of se.rum) 1,';9-S a.crI ecl to m2.YW
by a 3~1~le could be calculated from t~e percentage of the
added activity which eluted from the colurr~ bound to the
transcoba12.mins. )_ second estimate of the U33C could be
obtained for many of the sa~ples in this way.
Rat'1 ioactivi ty Pl83.su""emen t
TD9 samples were counted in a Fackard well-t~e auto
g8Jl1118 scintillation spectrometer as c'l.escribed earlier.':"
e tanda'rd solution of 57 Co cyanocobalamin was counted. with the
s~~ple3 and aGain prior to fractionation when the 4 ml serum
sample 57 Co 312 was cOQ~ted in the sodillffi iodide cr~ystal
linked to the scaler ratemeter. Thus the results could be
expressed as a percentage of the added activity.
The ::cesul ts of the studies in which vi t ami,n 312 was 8.dded
to serum ~~d its dist::cibution on the transcobalamins was
e s t ab'Ldshed a::ce n::cesented in tables 1R - 2C. The relev2nt
clinical data are also incorporated in these tables. TQe
distribution of the results in the control subjects (5rouP 7)
is shovm in table 2d.
TQe serQrn s~mples from the subjects in group 3 were
taken because of a history of low se~L~ 312 levels. ~De
level of 312 measu::ced from the sample at the time of study
was sometimes higher tha~ the level which had been determined
previously. ~~is increased value may be a true reflection of
the B12 content or it may be due to bacterial contarnination
of the samp'Le,
TQe estimates of unsaturated 312 binding capacity
obtained by charcoal abso::cption are also sho"ill in tables 18 -
2G. These estimates were plotted against the estimates
obtained by G - 200 and the distribution of values is shovm in
figure 12. A linear correlation was found with the regression
equation y = 1S0.5 + 0.94x. T~e correlation coefficient (r)
was 0.83 which is significant at the p = 0.01 level (n = 88).
The serum B12 levels obtained in the control subjects
almost all fell within the 'normal' range of 160 - 700 ng!l.
The two exceptions to this were the s~~ples obtained from the
two laboratory workers who routinely use cyanocobalamin in their
inYesti8'ations!
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Case Pretreatment Pont Treatment
No Age Sex FIb folate :812 UBBC TCO TCl TC2 Time FIb folate :812 UBBe TCO TC1 TC2
gJdl ngJl ng}l ngJl % dl ~~ g/dl ng/l ng/l ngJl % c/ %;0 /0
- -
1 75 F 10.1 12.8 60 1295 3·9 30.9 65.2
2 62 M lO05 10.8 30 1307 5.1 20.3 7406
- -
- - -
- -
~
3 52 M 12·7 2000 30 1195 2.8 31·9 65.3 1 m 13.9 - 1650 520 4·7 10.5 84.8
4 74 F 5·0 9·2 20 1084 1.3 6.6 92.1 5 m 14.6 - 1250 833 0·7 24.1 75.2
5 68 M 15·7 7·6 70 1413 0 22.0 7800 1 y 16.1 - 1250 1303 4.1 10.8 85.1
6 52 F 5·7 6.0 30 1564 1.6 14.2 84.2 1y2m 1407 4.0 750 2045 1.9 14.3 83.,8
7 59 F 6.4 3.4 20 '1692 4·1 14.7 81.2 2y6m 1809 - 2400 4510 0 42.3 57.7
8 78, M 7·4 4·0 40 1038 2.4 31.3 66.3 2y6m 15.0 - 3800 1319 5·3 11.1 83.6
9 58 M 6.7 4.2 80 - - - - 1 Y 13.2 - 200 3200 1.3 42.5 56.2
10 65 M' 8.7 9.0 200 - - - - 3 y 14.8 - 600 1469 3.7 17.3 79.0
Table~8ShowinB results from patients with established vitamin B12 deficiency states (continued overleaf).
Case Pretl:'eatment
PO~3t treatment
No Age Sex Hb folate 1312 UBllC TCO TCI TC2 Time Hb folate 1312 UBllC TCO TC1 TC2
gJdl ngJ1 ngJ1 ngJ1 ofo % % g.!dl ngJ1 ngJl ngJ1 % 7b ,,dI 1°
--
11 68 F 9.0 8·5 25 - - - - 6 y 12.1 - 1000 1917 5·6
6.5 87.9
12 68 F 9·0 8·5 25 - - - - 6 y 13.9 - 120 - 2.4
20.6 77.0
13 67 F 13.3 9·6 80 - - - - 7 Y 12.6 - 1000 ~750
0 31.3 6807
14 62 M 6.0 7·6 30 - - - - 8 y 14·9 - 480 1-256 7·1
11.3 81.6
15 59 M 8.7 - 40 - - - - 8 y 15·4 - 1500 4086
2.2 7.6 90.2
10 Y 14.8 - 3700 4669 1.4 5.4 93.2
16 74 F 7·4 - 60 - - - - 10 y 14.9 - 360 1382 3.8
22.8 73.4
17 63 F 14.0 - - - - - - 12 Y 14·2 5·2 750 1758 5·5
22.8 71.7
18 65 F 10.6 80 40 - - - - 17 Y 11.7 - 520 1344 109
11.5 86.6
19 26 F 3·7 - 50 - - - - 2y9m 14.8 3.2 290 1070
1.0 6.1 92.9
4y8m 13.6 3.8 100 1196 0 6·5 93.5
5y7m 13.6
-
100 1187 105 9.9 88.6
Tablel8:Showing result s from pat ient s ..lith est ab1ished vit amin 13 12 deficiency st at es -
Case
B12 absorpt ion
No Age Sex Diagnosis Hb folate alone +IF mar-r-ow MAO
B12 DBBC TOO Tel T02
gjdl nrYl me-q nrYl ng}l % li~ %
20 63 M Diabetes 15·1 4.8 5.0 4700 norma PFA
120 1545 5·8 1804 75.8
21 61 F It 14·1 1600- 3.0 39.1 normo PFA 95
1629 3.6 20.2 7602
22 79 F It 1301 1200 404 36·5 normo FF'A 70 1397
5·1 25.6 69.3
23 75 F Glossit is B12100:150 12.8 400 1705 4005 normo PFA - - 1.3 20.9 7708
6 ill later 13 .2 - - - - - - 1.0 23.9 75.1
2,6
~ -l(.
24 42 F Ent er opat hy 11·9 7.0 2.3 normo -
140 1420 0.6 14.8 84.6
25 69 M II 14.1 3.0 1902 41.0 normo 15·2
120 1927 1.1 14.4 84.5
26 65 M Gastrit is B1280:140 13 07 7.6 26.6 42·5 norma 0.2 220 1583 3·5 24.3 7202
27 64 F Post Gastrect amy 6y 14.0 5·2 14.0 9.0 - -
no 1635 3.3 19.5 77·2
28 56 M II 16 Y B12 80: 100 14.0 7·2 12.6 42.6 - -
160 1444 3.0 37·3 59.7
29 66 M II 20 Y 13 .2 5.8 18.0 54.0 normo -
60 1606 4.1 13.4 82.5
30 55 M It 14 y 16.4 - 10·5 - - -
200 1490 2.2 33.8 64.0
31 34 F Thyrotoxicosis
B12 120. 11.5 - 16.4 39·7 -
PFA DOO 1093 5·4 12.3 82.3
Tab1e l9 : Shoidng results in patients with latent vitamin B12 deficiency (Group 2)0
* Denotes Schilling Test result.
Case B12 absorption
No Age Sex Diagnosis Hb folate alone +IF marrow MAO B12 DBBC TCO TC1 TC2
gjdl" mil meq ng}l ng/1 % % 0'/0
32 79 F Malnourished 11.2 ')20.0 37 00 48.0 - - 140 1345 4.6 7.3 8801
1 m later 11.8
- - - - -
140 1304 6.3 9.5 8L) 02
3.6 *33 81 F Malnourished B12 120:150 11.4 14.6
- - -
230 1452 o 26.2 73.8
34 74 F Glossitis B12 110: 100 14.7 2.4 3900 28.0 norma PIi'A 210 n88 4 .3 24.2 71.5
35 75 F CVAB12100:100 12·9 5.6 35·0 42.0 - - 160 1620 2.6 14.8 8206
36 69 F Anaemia ESR 100
B12 130:140 10.2 7.4 7200 56.0 norma - 180 1477 3.3 9.1 8706
37 66 F Anaemia J!iSR 100
B12 80: 160 12·9 - 67·0 28.0 norm 0 acid+ 155 - 1.6 5.9 9205
2 y 6 m later 12·5 3.0
- - - -
100 1285 1·9 6.7 91.4
2 y 10 m later 12·5 - - - - - - - 5·5 800 8605
38 49 M Post gastrectomy
18 y B12 100:110 11.6 4.0 3700 4800 normo
-
160 1147 8·5 9 02 82.3
39 41 F Post partum B12 80:60 12.3 8.0 30.0 22.0 - -- 180 - 008 33.5 6507
40 51 F Post partum B
1f
100
*7 y la er 1209 3.8 19·0
- -
acid+ 170
- 1·7 5.7 9206
7 y 3 m later 12.2
- - -
normo
- - -
206 6.4 91.0
8 y later 12.4 3.8
- - - -
120
-
1.4 7.6 91 00
10 y later 12.8
-
44.0 43.0 norma - 190 1124 3·7 6.6 89.7
Table~QShov;ring result s: Pat ient s with low serum vit amin B121evels but having a normal, capacity
to absorb vit amin B12 ( Group 3) 0
.* Denotes Schilling Test result So
Pretreatment Post treatment
Case
No Age Sex Hb folate B12 UBBC TCO TC1 TC2 Time Hb folate
B12 UBBC TCO Tel TC2
gjd1 ngj1 ngJ1 ngj1 % % % g!d1 ngj1 ngj1 ngJ1 % ~ %
41 29 F 6·5 1.8 270 1243 0 42.8 51.2
42 28 M 10.4 1.6 140 1059 5·4 10.1 84.5 1 m 12.6 )20.0 220 937 5·2 14.3 80.5
43 58 F 17·9 2.2 480 1882 2.1 38.7 59·2 3 m 11·5 - 220 1174
3.1 23.7 72.6
44 68 F 5.6 2.2 190 2439 1.9 9·9 88.2 4 m 13.7 - 750
1504 3·9 10.285.9
45 68 F 5·9 2.2 240 1392 1.B 10.7 87.5 7 m 11.0 -
220 1646 2.1 24.7 73.2
46 63 F 8·5 1.2 80 - - - - 5 Y 12.2 )20.0 320 - 1.8 19.8 78.46y6m 11.3 >20.0 130 1184 3.6 12.8 83.6
47 42 F 4.3 0.8 130 987 6.1 9·4 84.5 10 m 15·4 3·4 - -
1.6 13.5 84·9
1 y 13.5 2.4 380 - 1·9 2503 72.8
1ylm 12·5 6.0 - - 0 62.5 37.5
1y6m 12.4 1.8 280 1068 0·7 21.2 78.1
1y7m 15·4 - 200 1018 0.9 16.2 82.9
2y7m 13 .7 8.4 300 1679 4.0 22.4 73.6
Tab1e21 : Shovring results of patients presenting with megaloblastic anaemia
due to folate deficiency (Group 4).
Table 22. : ShovTing results from patients presenting with megaloblastic anaemia of unclassifiod origin (Group 5).
* Denotes Whole Blood Folate
Case A1k
lITo Age Sex Diagnosis Bilirubin Phos Ast A1t Hb B12 UBTIC TCO rei TC2p mOl/1 iu/m1 iu/1 iU/1 g/dl ng/1 ng/l % ·1 %>c·
55 86 F Carcinoma pancreas 308 220 22 11 10·5 )1000 2047 2.6 17.0 80.4
56 60 F II " 291 237 140 88 11.7
)1000 1282 6.0 9·8 84.2
57 83 F " " 492 983 90 60 10.0 400 1950 1·9
20.0 78.1
58 70 F " " 362 248 67 60 14.0 440
1068 4·3 16·9 78.8
59 87 F " II 243 362 39 20 10·5
)1000 3601 0.8 59·1 40.1
60 62 F Gallstones 103 327 77 236 15·5 270 1857 3·4 4.7 91·9
61 37 F Biliary cirrhosis 147 372 440 425 11.3 600 1303 3.2 4.6 92.2
II 1 year later 446 508 296 112 12.8 640 1642 4·5 10.3 85·2
62 66 F Macronodular cirrhosis 65 78 72 47 11·7 750 1294 2·7 7·8 89·5
63 25 F Chronic persist ant
hapat itis 9 78 28 40 13 .9 - - 3.1 20.3 76.6
64 30 F Active hepatitis -
at onset 85 83 68 90 12.2 860 1565 3.4 8.8 87·8
2 Y later 9 50 21 25 13.0 130 1308 5·5 14.9 79·6
65 53 F Cirrhosis: Portocaval~
.shunt 4 y 19 70 29 21 14·2 500 1435 2.6 9·2 88.2
6 Y 22 95 32 23 12.7 400 892 7.3 6.9 85.8
Table2.'3: Showing results in patients vlith jaundice and liver disease (Group 6).
Case Age Sex B12 UBBC TCO TCl
TC2
No ngJl ngJl % %
0,[,
/
66 47 F 440 1168 4.7 10.2 85·1
67 24 M 8Go 890 10.8 11.2 78.0
68 5° F 500 1352 3.5 11.7
84.8
69 22 F 270 1232 8.7 12.2 79·1
70 24 F 660 1229 6·9 8,,9 84.2
71 24 M 300 974 4.8 10·9 84.3
72 40 F 440 1088 3.7 9 ·9 86.4
73 20 F 500 1145 4.4 12.8
82.8
74 20 F 160 1404 5·3 14.0 80.7
75 20 F 160 1686 3.4 24.6
72.0
76 51 F 250 1793 3.6 16.6 79.8
77 20 F 600 1090 6.6 20.2
73.2
78 23 F 330 1366 6.1 1l.9
82.0
79 23 F 170 1103 8.4 17 ·9 73 .7
80 23 F 710 833 3'07 11.1 85.2
Tab1e-24 : Showing result s in control subjects.
Case
No Age Sex Diagnosis ::812 UBBC reo TCl
TC2
-
81 50 M Tobacco amblyopia. Alcoholic 250 -
1.3 3.8 94·9
82 52 F " "
· 130 1760 3.4 34·9 61.7
83 66 M " " · 260 1472 4·7
17 .7 77 .6
84 72 M " " ·
190 1939 2·5 17 .4 80.1
85 52 F "
II
•
200 1171 3.3 8.7 88.0
86 68 M II II • 430 1819
4.0 25·2 70.8
87 13 M Lebel's disease 150
1234 4.8 9.6 85·6
88 13 M "
II 800 1135 2·5 6.1 91.4
Tablel-s'ShoVling results in patients vlith toxic amblyopia and Lobel's di soaae (Group 8).
Case
No Age Sex Diagnosis B12 DBBC
IJ:\OO TCl TC2
~l nrdl 01 d vi/0 /'0 ...i:-
89 46 F Acute myeloid leukaemia 550 1240
2.1 10.5 87.4
90 71 F Chronic lymphatic leukaemia - - 0·9
13 .9 85·2
7 w later - - 0.6 31.7 67·7
91 35 F Drug overdose 190 1684
4.1 16.8 79·1
92 39 F Errl;erop.:lthy. On folate anc1 diet 190 1164
4.0 14.8 81.2
93 58 F Chronic renal disoase 300 2181
2.0 11.5 86.5
94 '70 :M Cerebrovascular accident 400
1422 ~.2 13 .9 81.9
95 68 F Rheumatoid artlU'itis 150
1128 2·9 8,2 88.9
96 8m M Anaemia ? type - -
2.8 15·4 In .8
9'7 4'7 F Hypertension 530
2028 4.2 23.8 72.0
98 80 F Peripheral neuritis 170 1304 3·9
6.4 89·7
99 59 1.1 " "
160 1169 0 28.2 71.8
6 m later 200 1857 0 36.9 63.1
100 5 F Daughter of Case 19 660 1948
5.0 8.8 86.2
'l'ab1e:i!.~showing results in patients with miscollo.neous disease (Group 9).
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Figure 12 A com~~rison of the unsaturated B12 Dindin~
capacity of serum samples as estimated oy aloumin-
cnated charcoal absorption and by Sephadex G - 200.
TDe initial vroolem ~hich is ~resented oy these results
is to decide ~hat can reasonably re de3crioed as nornal.
The distrioution of samples in the control grunp mayor
may not 'be Gau3sian. If it is assumed t1B,t they can be
descrioed oy a Gaussian districution then the nOr;:1al ran;se
of v"tlues could oe taken to be mean -r 23.:0. Ove:r 95< of a
no~,al population are included in this range
This would give no~al values of:-
TCC
Tel + III
Tell
1.2j', - 10.0,:,
4.8 - 22.4'
71.L1 - 90.2
Cnly tffO of the forty-five values obtained in the control group
fall outwith these raIl..ges. The TOO peal< was not consistently
oose~jed and therefore the lowe:r limit of the :range was not
8.-pplied,. T:'1e only sample which hound more than 10C, to TCO was
found in the cont~ol xTOUp. It '~as found that forty-t~o
sam-ples (of a total of 137) fell outwith this 'nornal' r~~e.
Thirteen of t'c).ese bound. more than QO.2;', of added activity to
TCII and twenty-niYle bound either less than 71.4,< to TOIl or
more tlVJ1 22. to ~CI + III or ooth. The twenty-nine s~~ples were
reduced to the eleven 'most a'bnormal' i.e those which oOlh"ld more
than 30, to TOl + III. Tnese sa~ples are listed in table 27 as are
TCT + III Tell ,:rroup
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Taole 27 a) showi.nz results from. pati errt.s who OOUIld
O~ : ~ r<' d. 57" "'"' ').L rrvvrmore than 3 .. 01 auc.e vo.')1 ~ to .cv.L
+ III.
TCT + TTl Tell grou.TI
81 3.8). qLi qel. 8~ ....... i
19 6- 5/: q 3· t;' 1J,"
1 t:; 5.·t' 93. 2 j': 1
.,I
19 r r' 92. q", 'lc .
LiO 5.T' 92. 3
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((\ 4.7< 91 · 9~~ 6.~
53 '7 91 .T h..I
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37 C.7;' Q1 · 3
t7 0 6.4', ?1 .0/ 3
40 .., e-: 91 rv:. 3I
·
• .....J,
Taole 27 0) show.i.ng results frOB yatients ':7L10
S7
bound Bore t112,n '-:;0.2 of adde:i -" Co "312
to TGll.
t':le semples vhich 'bound Bore t~nn 90.2,' to TCII.
T~e Been yercentaC8 bOlli~d to each protein TIaS cqlculated
for t"'l.e patients in eac:!. g-r,::)Lr8, as 'was the s tandard (.leviation.
The results did not appear to differ si~iificantly from those
obtained in the control [rou}) (se·a t8.o1e 2(0).
~~e significanse of these abnormal results, if indeed
they are abnolillal, is not l:no~n. lhey are not related. to
86e or sex nor are they confined to, nor even predominant
in, ~~y one clinical group. TI1.e poss i bility t"hst they E'~ght
correlate withse:cuffi vi tSEir~ B12 level or w.i. t':} the unsatl,J,rated
B12 binding c9.yacity wae a'l.so ex ani.ned and eli;ninatec1. Iro
cor:cel<.dion was found bstween Low s erum :212 level and the
p8rcent;:tge of ac t i,vity bound by Tel + III. The aarnpLe s
obtainerl from patients in grouy 3 ';;jere e::8.mined as 2, r O .3 s i bl e
source of Tel I III deficiencies. Tne features which were
characteristic of the €roup (low serlli~ 312 'out nOl~al absorption)
appe2red to sugi:,est either a d.i e uar'y deficiency of J312 or a
Tel deficiency. ~;o such transcobp~l8.I11.in deficiency was observed
Dowever inasmuc~ as all the samples bo~~~ some addei 512 to
rrCI+III.
It se~ms reasonable to conclu~e that measurements of the
distribution of adr:ed 312 on tl'18 transcobalcunins 1'18.ve no -oractic2.1
value at tDe present time, apart from the cases of transcobalamin
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Group
::'~urnber
1 - pre
?10. of
a?.rrroles
'<-0
mean
o -,
r.•• 1.7
Ie I+lli
mean
?~ ~
.. I. ) 75.3
3D
1 - post
2
3
L1 - pre
4 - post
5 - pre
5 - post
6
7
8
9
20
13
15
,
(;
12
3
o
15
14
137
2 '7• I
3.3
2 q
- ..
2.5
1.2
1.6
5.6
3.3
2.6
2.1
1 .7
2.3
1.6
1.5
1.5
1.7
2.2
1.2
16.7
21.4
12.0
20.3
2?2
15.4
17.2
11.4
7 C
, .'-
o '7
...
1.4
13.8
4.4
10.6
9.4
80.t
75.5
80.7
80.8
81.3
80.2
10.8
7.6
14.5
12.9
8.3
12.9
L1 '7
, • !
11.1
8.4
Table 28 showing a comparison of the mean values
of the percentage of added B12 bound by
samples from subjects in each group.
deficiency. TJ...Lv is poss i 'bl e that if det?,.ilsof ..!..... .t:"cne m'3..SS o i
tra.'1scoosI2:nin present 2nd of the distribution of endogenous
1312 on the trnnsco'o8.1:?:nins were known t~'len the results misht
be more mea.lin~ful.
A compari30n of the methods for separating free a.'1d
~ley did not eX'3..:nine serlliu but reported that
for human gastr.ic juice, bile and saliya there was no
significant difference between the results obt~ined ~ith
gel filtration (G - 10) and. with coated charcoal. In contrast
t t ' · I ...... ( 0 ,18 \ ~",.- ,o ru.s 3, poor cor re a't.ion \r = .4) was r ounn oy :-~om ana.
}~luwalia (28) for TI33C values as measured by 3ephadex G - 200
and coated cha.rcoa'l in asalTIple of fifty subjeds.
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C H A ~ T E R 3
TO STTJDIE3 ON TIlE
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-::ntroduction
Sep~~dex G - 200 was used for the separation of the major
co balarnln oindin:3' proteins throug~'l.Out tlls s t ud.i.es dsscribed
in the precedins c:1apter,'j. It W2."l cho sen initially becs-use
it appeared to he the method used most f r equerrt.Ly by previous
worke.rs p...nd t}1erefor~~ a.. d.i rec t Cosy,~,ri30n. could be D?Lcte Viit':1.
their findings. Gel filtration wit~ Sephadex G - 200 is 2.
resul ts show ::J, high degree of consistency.
,nterr-ative fraction2.tion rnat8ri8,1'3 have be8n ilroposed recently
for the separstion of the tr:mscohs13rnins. This ch:::,pter describes
some of ti1e resul t,q 0 bt"_ined by t'lese met:10ds. :::Jirect corn-
I8rison3 with the results oht"Lined usi ng 3ep'n"Jclex G .; 200
have been mad e ,
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It has ~een reported th~t ~Cl can be separated from
were therefore carr.i ed out w.i. t.h 8, view to using :C2_~3 in
conjunction with 3wghacLex G - 200 in order to obtain
results for 3,11 three proteins.
~aterials and methods
A 1 mI. sample of ser~s was applied to a colurrill
conta..ining _ cellulose anion exchange
-~ t'li'.en I.
The resin had been pre-treated in accordance with the man-
ufacturer's instructions. Tae ser~ sample had been labelled
wi th 57Co B12 and the excess B12 removed with alhl-min-coated
charcoal as described before. 'rh.e se rum W8,S eluted from the
ion-exchange resin with approximately 30 ml. of 0.06 ~.:
phosphate buffer followed by 30 mI. of TI,{ ~~aCl. These fractions
were connted for radioactivity in a sodium iodide well
crystal connected to a counter ratemeter ~!I3 310.
The buffer eIuarrt -;. approxim8.tely 30 ml , of distilled
water were concentrated to 4 mI. by ultrafiltration with an
\micon cell (model 52) at a pressure of 83 kPa supplied
from a nitrogen cylinder (British Oxygen Company). The sanp1€
was fi1 tered t~'lrough a "JE - 05 membr-ane whLch retains all
•
molecules> 500 A.~.U. The filtrate was checked and found
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'r~e 4 ml. s~myls3 obtained ~ere ~p~lied (s8~~rately) to
the)e:p~ladex G - 200 column described ea,rlier. T~'1e fractions
.~v~1ic·:l Rluted war-e 88..en counted. for 10 minutes in the T3.ckarcl
?JJ.tomq.tic gamrn3, oourrt e:r ,
"1esu1ts
BJ.. of the r.:J,dio"l.ctiv i. ty w'1ich W"l.S recovered from tl'le
J31£ cellulose was eluted fro~ the co11h~n with buffer ~J1d
therefore corresponded to
Bloomfisld and 3cott (1;1). The resaining 15.1~" eluted with
molar saline and was t~lerefore Tel:. '.'il'len t'18se t'NC fractions
were run on 3ep1ndex G - 200 they bot~:1 cont~.ined. <,_pproxim?tely
34~', high molecular weip;ht bin(1"er and 66( low molecul~r-"eight
binder (~ctual values for low molecular weight were buffer
eluOtnt 66.1;', sa.l t eluant 66.50').
T:'1ree aamp'l es of se rum f'r-om t':1e sa:rle norma'I pool were
recovered ~ctivity chich was eluted wit:'1 buffer W?"3 84.5';',
83.7 em:: 82. r'. These values are s i.mi.Lar- to those reportect
by }31oo~field and ~3cott.
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T'r18 buf£'er and 38.1 t e Luants f rom th~" first tCTO 8Cl'7rples
",Yere s130 se:9"Lr;;:3;ed. on C'- - 200, and t":1e dis t.r-i,'hution of
57 Co :B12 was :
Tel +
Teo -r-v-r-r- rcr rI .L'
buffer eLuarrt (1) rv n·····' 25. t4. 8~-~:/ .0.-
H
" ( 2) 16.Ll': 53.6;- 30.0;
salt eluant (1) 1 .8, 32.4' t5.8;..
tl tl ( 2) 4.8', 29. 65. e.-
At this poIrrt the experiments v,ere discontinued bec8,'.lse
the IJ'..~~;~ - cellulose fractionation did not ap-pear to separate
from TCII and TOIII. It would haye been useful to have
studied tl1e re~Terse seJ)~...ration : fr3..ctionation of the Tel -+
III neak from G - 200 and also the TCII peak from G ~ 200 on
TIEAE - cellulose. This was not possible however due to the
presence of 12 ~aCl in the buffer used for gel filtration.
Discussion
3xperiments of this nature have also been carried out by
Gizis et 8,1 (31). They fractionated the ])3)li - cellulose buffer
eluant on 3ephadex G - 200 and observed only one pe::l-k (at a
molecular weight of 36,000). The diagr~~ which illustrates
this observation does not however show s clean sharp pe;;:~
at this point and it could possibly be interpreted as cont~ining
more th::m one B12 binder. T~ey also sep",-rated t~e TCl pe ak
(sal t eLuan t fro"1 DE.',,~:; cellulose) and. observed two pe aks of
The first (ap"iroxi:rrt::;,tely 67,;' of the eLut ed
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57 Co B12) correspondecl to the elution V01U.:118 of Tel and
the second (33:) to TCn:.
and 3cott (1L1.). 'I':::::t-leflonstr'tted th8t the 'buffer aLuarrt
from ICA-:; - cellulose ccmtained t-"o yr;teins (Ter:;: and
TeIII) 'by virtue of their different elution volumes on
Sephadex G - 20C. There were however no re.sul ts to S''lo''.Y
that the 3'3,1 t el\l2cnt from D:~A:~ ·W?S hO'1logeneous on Sephadex.
At the time of the e~periments reported in this section
the failure to show that the s?~lt eluant f'r-otn DEA:~ contained
only one protein was attribut.ed to lack of f?..niliari ty in
handling the ion-exchange material. Consistent results
»ez:e ho-;,ever o'btained from' t'18 simple elution of the sample
f rorn :I};j,r::;. It is -possi'ble th8.t the -pro1)erties of t~1e -prot,eins
( 20) t~1.2.t the tr8nscohal8.c,ins are very labile ·proteins.
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TIltrqfi1 tr2.tion
)', v:,.riety of rn8rrlbr"'.ne s i zes are 8.v'1,ila'ole for th,e Amicon
ul tr;:Lfil tr'1,tion cell ::J.~\:: it 7n:3 deciCied. to seA 1I ;my of
tn.ese wou.l.d be su i. t8.'ole for the 3ep,;1.r~,tion of the trs,nscobala::nins.
The molecular weig"l.t'3 of the J312 binding proteins whi.ch have
been reported by different groupS of workers h8ve varied
slis-htly but va.lue s of 36,000 (TCll) and 121,08~; ('I'CI + IE)
seem to be reasonable estimates.
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:')'8:+'8"-; 3.13 ;:JUG. methods
'2:'hese exyerii'1ents were carri8d out us::"ng 0.5 mI. of
serum 12.be11e(1 vi, th 57 Co B12. The ur.bounc vit;oLilin :312 was
removed by absorytion on to aIbwun-coated char-coa'L as
described earlier. Tne S8rlliil was ylaced in the cell
(model 52, Ami con Coryoration, Lexington, ~'=ass.) and the
volume was made up to approximately 50 ml. with infusion
saline (0.15I~ lJael). 'I'he cell was att8-ched to 2. cylincter
OI nitro~en (British Oxygen Comyany) and a pressure of
83 y.:Pa W;:>~3 appLi.ed , )l.fter the voItrae ~'18.d been re::1uoeo to
around 5 ml. the cell was toyyed up with saline solution.
This was repeated until a total vollliile of 150 ml. was eluted
There are two membrane sizes ~Tnlable which were thought to
be sui table for this study : the Y2,1 - 50 which retains molecules
') 50,000 :1..1,;.U and the ~GJ: - 100 whi.ch ret8.ins tl'lo se with a
molecu18T weight greater th;:m 100,00:).
Results
Tae first experi;,-ents were c8.rriea out Vii th t1:1e ;2,: - 100
membr;:rne. Po, comp?"rison of these res',ll ts 'I'd th G - 200 fr".ction-
ation sho~ed that not all of the TCll bound radioactivity ~as
passinZ throu6h• ~ven less of the Tell - 57 Co 312 was filtered
in the experiF'ent with the XC'~ - 50 mem'orane. T':18 re3u1 ts
obtai-ned 'by Amicon cell ultrafiltration were neit'cler ccnsistent
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::::eru.;n
number
1
2
5?)
5'0)
- \jC)
5e)
./i:nicon
-;- III) ~'lt t (1':":T\Il_ r~ e \ -_.~__ )
3en~1?QeX
Ter +-1lI TeIl
'1':.:;h1e 29 sho-"dns the differences in the 2epar~tion
result:s obtained from Sep':1aclex G - 200 sne.
ultra,fil tra-tion.
All eamp l e s were ccricerrtra't ed at s, pressure of
83 ~'2 except 4'0) 'l'illich Vias at 2" pre.3sure of
~: - 100 membrane in each case.
Five different seru~ s~~~les were used, re~licate s~mnles
\
8-5 ?.), b), c) etc.
Tl1e rno o:t disconcerting aape c t of the results was the rate
a t which t':le fil terec- r?dins,ctivi ty W2.3 recoYerea. An eX?'''''':;lle
of t~is is S~'107m in a s?'i}\le of serum f'r-orn C?se A w~en the
67.5:' of the r':u'1io;'lctivity ?!"L'3 'i"<Jl.e un of the folloviing
amourrte (e?,ch referring to a voLune of a~}\roxim:'ttel:r 1S ;-nl.)
Fil tr;::;,te
1 17 .0,
2 12.7,'
3 10.6,:
4 5. 2',' :
5 7.1
6 r: reiC· .e··
7 3. E(
R 3. C{
A fnrt'1.er 20 ml , of s8.line was ?,Gel ,ed, and when fil tereo it
contained, O.w: 0: the total radioactivity.
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:Discussion
It nov appears that the molecular v(eights of both biClders
of 121,000 for Tel + III were due to a high carbohydrate
content whic~ is responsible for its altered elution fro~
,;ephs.dex G - 20:J. The value abt8.ined for Tell clp:;:ears to
be t:le rasul t for only one of its :peptide cha.tns , :W there
is now evidence (26) that the molecule is a dimer.
In the light of this new information there is no reason
to expect that the :proteins can be seu8.Tated by ultrafiltra.tion.
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};JnmOni1.1;:'l 3ulnhate llrecini t8,tion
The lJo1yf r 2-c t i on ? t i on of s e rum by protein precipitatioYl.
with amrncn.i.um sulJ'J{l'tte, CJ'~4) 2)04, wa.s first reported
This method h~s been adapted 2nd reported
2.3 silltalJle for the separation of the vitamin 312 binding
proteins by two separa,te grouj)s (81,82). Alt':'lough
differiC1§; slightly in the details the two methods described
are ve~{ si~ilar.
?;~aterials ana :~ethods
Vethod 1 (Carmel)
~\ simple one-step separation using 0.5 TIl serllill, 1.4 I'll
0.4E K
2HF0 4
and excess 57 Co 312. The unbound 312 W2.S removed
by adding this mixture to a tube containing 3, :pellet of 1 : 20
hae~oglobin-coated charcoal (prep2,red by centrifuging 1 I'll
of coated ch?,rcoal sU3:gension and sucking off the supern?bnt.)
The serum 'bound :B12 (in the ch2Tcoal tre?,ted supernatcmt) was
8,dded to a, tube ccntuning 4 I'll. of 3=-: (inA) 2 ~C4 8.TI<'1 mixed
by Lnve r s i.cn- T,l.8' mixture was .i.ncuba't.ed for 30 minutes
pt room tem:perature followed by centrifugation for 15 minutes
at 3,000 x g. T_'l8 r.2CII bound :312 VIas p:cecipi ta:ted under t~1ese
conditions 'but t'1e 'reI -;.- III bound :312 remained in the superns.t?!'J.t.
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2 T'1.1 of serum ''i~S 1;:1.1)e11ed with
t=,7
excess J Co 312,
incubated 8,t 370C L' ?(\ ..j.. 1 ,', •. .Lor ,_" 7')1.nu "es, 8..1'10 Gl8,.Lysed
(fine.l P~l 7. L1) to re:nove free 312. Half the samnle V''''3
mixed wi tll 0.1 ml of 1.)H sod.Lum acetate (p~l 7.2,) and
brought to final vo Lume of A ml with distilled ]20.
':30, W,lS ad.d ed and d i ssol v",d Ln 311'1"'.11
L~
amourrbs ,
~0e s~'1l}Jle stood 17 - 18 hours at AOC before centrifugation
o
at 17,300 x g for 30 minutes at l C. The TClI - 312 was
precipitated by this process ?~'1.d TCI + III bound 312 was
left in the supernatant.
Serum samples from ten subjects were used in the
experiments described here. An aliquot of serQ"l from each
had previously been separated on 3ephadex G - 200 which neant
that a comparison of results was possible. T:le s~uples were
chosen from patients who appea.red to nave an abnormal 'bi nd.Lng'
pattern.
The procedure described by Carmel was followed exactly, apart
from the substitution of alb~~n-coated charcoal for haemoglobin-
ocat ed charcoal. Four samples were prepared for each subjects :
to two of the!'1 22,1 (N:.r4) 230A. was added and to the remaining two
There is ambiguity in the paper about WQich of
the two concentrations of a~~oni~~ sulphate solution was used.
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T:18 method o.escribed by Begley "mel -'{all ';,':1-:'3 followed. with
the removal cf f-ree 312 hy albunin-cop.ted charcoa'I (1 m})
instea,i of d.i.a.Lys i s , TJ'roliC'1,te s?,n1yles "ere also used
in this metho d ,
Results
The results (the mean val~e of duplicate samples)
are given in table 30. The precipitation wi t.h 2;';~ 'aTiffionium
su.Lphat e solution did not give results compa,ra,ble wi t':1
G - 200 : very little protein was precipi tel-ted at this
strength and these results are not incluoed in the table.
A good co.r.re'La't i.on was obtained. between G - 200 ani Je'I
ammorri.um sulphate -precipitottion (r == 0.94, n == 10) and "'_1so
bet-.veen the :Begley and 112~11 methcd and G - 200 gel filtration
(r c= 0.?1, 1'\.== 10). Tn.ere was "'.lso a good cc\rrelation
between the results obtained from the two charcoal methods
(r == O.qs, n == 10). T~ese results are significant at the
:p = 0.01 level.
Discussion
The two methcds described are basically very s LrniLa.r :
the ma.Ln differences are in the buffer us ed , the length of
time allowed for :preci~itation and in the speed of entrifu5ction.
The pellet obtained is fimer after high s~eed centrifuzation
and t'Y)is make s it 8ssier to remove the sunerna.tant without
disturtin~ the precipitated ~~otein3. The effective con_
centra.tion of ammcn.i.urn 3ulpha,te in t~le final so'l.irt.ion is Z'~
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Case
no.
8
10/
28
39
41
44
65
r;:ahle 30
Ca.rmeI ammoni um Lesley'& :-J:all
sl11p~'1,~~te ammorri.um suLpaa'te
~raci~itation nrecinitation G - 200
showins percentage of added activity
hOQDd by Tell as determined by three'
different methods.
in the C ":-n<el method 'mc:.2. 25:: in t'le technicye described. by
329;le;7 2nd:~all. ).t a concentration of 1.5 - 2. 3i~ TClI is
preciyitated whereas to ottain preci~itation of TCl + III
one must use a 2.5 to 3.5"" ammorri.um sulphate solution (8)
:~it':1er of the t'eTC> 711ethods descrited here would be snitable
for a rapid routine separation of acld.ed B12 into TCI + III
bound B12 and 'I'CIl bound 312. Tile method described. by Begle:r
and Hall Ls slightly more l~:J)o:rious 'out gives results whi.ch
conrpare '."ell with those obt8.ined by G - 200. Tele res1).l ts
obtained fro~ the Carmel method ar-e
. . ,...., .
lD nln8 01 ~ile Gen cases
a very good correlation was obtained. bet7veen the values
obtained by the Carmel method a t test of the differences
betweeYl t:'12Se results and t':le others showed that there was
a significant difference between t':le values. T':1is is due
to the increased magni. tUlle of the r2sults o cta.i.ned by the
C::;.rmel method. There was no signific2,nt difference at the
P 0.01 level bet~een the results obtained ~ith Sephadex
G 200 and w.i th the 3e£1,ey ana '{all preciljitation tec'1.n i'lue.
Al thoug:1. the method de scr'Lbed by Begley and 'lall (82)
gives results which are closer to those obt"'"ined 7ri th G - 200
. than 1'1"'_3 fauns u s i.ng the C8,rmel T'lethod (81; this study was
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It would be
necessary to use a lar:~'er s ampl e in o:!:'der to make me"!.nin~ful
comp~risons of the methods.
In addi, -tion to t~"1e th:r:e8 separ=dion methods described,
the 312 binding proteins nave been f'r-ac t.i.one.t ed by conventional
~ethods of protein separation e.g. polyacry18mide gel
electrophoresis as weL'l, 2.3 by some more unusual, methods.
Included in the latter category are:
. '\1; the use of zirconyl phosphate gel to selectively
ii) the absorption of TCII on a IT~crofine
of silica (~u30 G32) (84).
iii) the separation of the proteins on charged cellulose
filters: trapping ~CII on cellulose-nitrate filters
Bud Tel on n~-81 filter discs. (85).
It is possible that one of these separation methods would
also be useful for rapid d.i.agnoe t.i,c purposes. 'Hhet~'ler this
information would be of value clinically is perhaps another
matter, for the spread of results observed in the preceding
chapter night indicate thg.t information on the distrrbution
of "ldded 1312 would be of little practical value.
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